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Abstract  
The sigma non-opioid intracellular receptor 1 (σ1) is a highly important, yet poorly 
understood chaperone membrane protein. Although structural studies have come 
a long way in identifying the crystal structure and its pharmacological 
characteristics, the proteins relation to disease and illness is yet to be fully 
established. Currently a world leading biopharmaceutical company called Anavex, 
is conducting phase 2b and 3 clinical trials on a compound called A2-73 to target 
the sigma-1 receptor in Alzheimer’s disease. This compound has demonstrated a 
good safety profile and significant therapeutic effects in some patients by slowing 
Alzheimer’s disease progression and even reversing its development if treated 
within early stage onset.  
 
This research project aimed to develop recombinant protein expression systems 
for the sigma-1 receptor in C43 Escherichia coli and INVSc Saccharomyces 
cerevisiae cell lines. In addition, we set out to compare current detergent 
solubilization techniques with upcoming nanodisc technology, as previous 
publications have demonstrated undesirable results when conducting structural 
studies on this protein. Here we report, the successful isolation of the human 
sigma-1 receptor in C43 expression systems and effective solubilisation using 
detergent based methods. Unfortunately, we were unable to solubilise this 
receptor using nanodisc technology in any of the expression system we used 
during this study. In addition, we were unable to conclude the definitive isolation 
of the sigma-1 receptor in the INVSc1 cell line due to potential cloning and 
expression protocol issues. However, we did report positive results for the use of 
nuclear magnetic resonance (NMR) spectroscopy in ligand interaction 
experiments such as CPMG studies. From these results we identified a plausible 
binding interaction between the sigma-1 receptor and the agonist compound 
fluoxetine hydrochloride. However, this result was not entirely conclusive due to 
a possible indication of the agonist binding to micelle formation from the use of 
detergent. Overall, this study highlighted the challenges and potentials of 
researching the sigma-1 receptor and provides a strong indication for future 
research. 
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1. Introduction  
For centuries scientists have attempted to unravel the complexities of the human 
body.  It has only been made possible through scientific research, clinical trials and 
medical experimentation that proteins are a key biomolecule in the development 
and progression of disease. Breakthroughs in both chemical sciences and the 
biosciences, has made it possible to express, purify and characterise proteins on 
the atomic level, enabling us to understand the underlying pathologies in a range 
of medical conditions. In the last century, it has only now become possible to 
identify specific genetic mutations or aberrations in disease enabling us to identify 
which synthesised proteins are affected. This is a major development, as it enables 
us to develop investigational medicinal products (IMPs) to target these proteins 
directly or indirectly to eradicate a variety of diseases. The majority of human 
proteins can now be studied effectively through expression vectors such as E. coli 
which has enabled scientists to conduct biochemical pharmacology research prior 
to human experimentation with potentially dangerous pharmacokinetic and 
pharmacodynamic IMPs, in early phase clinical trials.  
Furthermore, the United Nations (UN) have forecasted that the global population 
is set to rise to 9.8 billon people by 2050, which health experts suggest will put a 
major strain on health sectors across the world. This increase in population is 
more than likely to result in an increase in disease rates across the globe. Because 
of this, it is more important than ever to research potential therapeutic target 
proteins to develop drugs that will potentially save or improve the quality of life 
for millions of people. One of these proteins that requires extensive research is 
the sigma non-opioid intracellular receptor 1 as it has been implicated in a 
profound number of physiological and psychological condition. Although there 
have been major breakthroughs in identifying the biochemical structure of this 




 pg. 12 
1.1 The Sigma Non-Opioid Intracellular Receptor 1 History and Background  
In recent years there has been a major increase in the studies of the sigma non-
opioid intracellular receptor (σ1). Over forty years ago in 1976, Martin et al 
hypothesised the existence of multiple opioid intracellular receptors that mediate 
pharmacological effects of morphine and its direct analogues1. Following 
extensive pharmacological investigations Martin et al classed these opioid 
receptors based on specific Greek symbols depending upon the ligands that these 
receptors mediate, for example mu (μ) opioid receptors bind to morphine to 
produce analgesia and kappa (κ) opioid receptors cohere to ketocyclazocine to 
induce dysphoric and anxiety effects1. Years later, in 1986 Su et al identified the 
true existence of the sigma class of receptors and their pharmacological 
characteristics. After carrying out numerous selectivity assays it was determined 
that the sigma class of receptors do not possess a high affinity for naltrexone, 
which all of the other classes of opioid receptors do bind to. This unique 
pharmacological characteristic of these receptors is a clear distinction that sets 
these proteins in a completely different subtype2.   
Following this discovery researchers were highly motivated to investigate the 
sigma receptor class of proteins to determine their physiological functions and 
potential implications in disease. A book released in 2007 called “Sigma Receptors 
Chemistry, Cell Biology & Clinical Implications”3 clearly outlines an overview of the 
sigma class of receptors pharmacological characteristics and describes their 
physiological functions in homeostasis & disease. This book contains an excellent 
collection of chapters from lead researchers across the world, to which provide an 
in-depth analysis of the sigma class of receptors. In the first chapter Dr Rae 
Motsumoto from the University of Mississippi describes that the sigma class of 
receptors consists of two distinct proteins; σ1 and σ2.  These receptors can be 
distinguished from each other based upon their molecular weights, tissue 
prevalence, and drug selectivity patterns. Both of these proteins are currently the 
focus of major research as their cellular signalling pathways are yet to be fully 
established. 
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1.2 Cellular Functions, Signalling and Chaperone Activity of Sigma-1 
The sigma-1 receptor consisted of 223 amino acids and is encoded by the 
SIGMAR1 gene, located on chromosome 9 at position 13.34.  The sigma-1 receptor 
is profoundly expressed in neural tissue such as glial cells, oligodendrocytes, 
microglia and astrocytes. The fully synthesised sigma-1 protein resides anchored 
in the endoplasmic reticulum (ER) of the mitochondrial associated membrane 
(MAM). Currently, there has been no identified soluble cytoplasmic state of the 
sigma-1 protein, and it is believed that its chaperone activities are facilitated in a 
membrane bound state. Chaperones are proteins that facilitate the correct 
covalent folding or unfolding of other proteins in order to regulate a specific 
cellular activity. The sigma-1 receptor is a known chaperone of the inositol-3-
phosphate or IP3 receptor, which is a protein also residing in the MAM. The 
activity of IP3 receptors are regulated via sigma-1 to ensure proper Ca2+ signalling 
between the mitochondria and the ER5. Under normal conditions cellular Ca2+ 
signalling is maintained to normal homeostatic levels, however when there is an 
increase in intracellular stress that reduces ER or Mitochondrial Ca2+ signalling, 
sigma-1 translocates to eradicate apoptotic cellular activities whether that be 
extrinsic signalling or intrinsic. This activity demonstrates sigma-1 plays an 












Figure 1: Demonstrates homeostatic Ca2+ ER and mitochondrial cell 
signalling facilitated by sigma-1 chaperone activity on IP3 receptors6. 
The Sigma-1 Intracellular Ca2+ Signalling Model. 
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1.3 Implications in Disease and Illness 
As the sigma-1 receptor functions are crucial for cellular survival under cell stress, 
abnormalities in its structure and down regulation of its activity have been 
theorised to play a significant role in various diseases. Some of the most notable 
physiological and psychological conditions sigma-1 has been linked to include 
depression, Alzheimer’s, Parkinson’s, Huntington’s disease, neuropathic pain, 
cancer, addiction and Amyotrophic lateral sclerosis (ALS). As the sigma-1 receptor 
is highly expressed throughout the central nervous system its links to 
neurodegenerative disease have been implicated. Specifically, in 2011 Al-Saif et al 
demonstrated that an E102Q autosomal recessive mutation in the SIGMA1 results 
in juvenile ALS. This study performed homozygosity mapping and direct 
sequencing of extracted DNA from peripheral blood samples taken from patients 
suffering with the condition7.  
 
In addition, this study demonstrated that mutations in the SIGMA1 gene reduces 
synthesised sigma-1 distribution throughout the central nervous system and there 
was a significant reduction in cell viability studies in these patients. This study 
supports the theory that the sigma-1 receptor plays significant functions in 
neuroprotection, and potential drug target upregulation of this protein may prove 
to have a beneficial therapeutic effect in some patients. Another study published 
in 2017 by Gueguineo et al identified that the sigma-1 receptor may play a 
significant role in the hallmarks of cancer. In this study they identified that 
activated sigma-1 under cellular stress increased calcium influx by coupling 
between SK3, Ca2+ activated K+ channel (KCNN3) and VI calcium channel Orai18. In 
the hallmarks of cancer, calcium signalling is a key process hijacked by many 
carcinogenic cells enabling cell migration in patients with metastatic staged 
cancers. Furthermore, Gueguineo et al also identified that inhibition of the sigma-
1 receptor through molecular silencing with a known ligand igmesine, resulted in 
decreased SK3 current and Ca2+ cellular entry in breast cancer patients. These 
findings are astounding and demonstrate that the sigma-1 receptor could be a key 
therapeutic target in a range of disease and illnesses.  
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1.4 Molecular Structure and Chain Sequence of Sigma-1 
The sigma non-opioid intracellular receptor 1 has both a unique molecular 
structure and sequence identity when comparing to other known proteins. The 
sigma class of proteins belongs to the ERG2 family of proteins and shares 33% 
identity and 66% resemblance to the fungal Δ8 → Δ7 sterol isomerases9. Over 20 
years since σ1 was first sequence, the crystal structure was finally solved by 














Figure 2: The Crystal Structure of Sigma-1 bound to Compound PD14441 In a Free and 
Transmembrane State (PDB Database 2019)10. The Identified Crystal Structure of the 
Sigma-1 Receptor. 
 
This publication revealed that σ1 possess an atypical fold with a single-
transmembrane topology. In addition, the crystallization of the protein revealed 
σ1 is folded into a trimer with a transmembrane domain in each corner. In 
addition, the Shmidt et al identified that the crystal structure of the sigma-1 
receptor possesses a cupin-like β-barrel with the ligand binding site underneath 
the centre of the domain. This binding site has been described as highly diverse 
for ligand recognition even if two different ligands possess different chemical 
properties. In addition, it has been identified that many ligands for sigma-1 such 
as PD14441 tend to form a charge to charge interaction with a glutamine at the 
amino acid position 172 and takes place at high affinity even If the binding 
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1.5 Introduction to Expression Systems for Sigma-1 
 
The expression and purification of recombinant proteins using bacterial vectors is 
well documented and is typically the preferred system to isolate desired proteins 
for research. However, many studies have demonstrated that yeast may prove a 
more efficient expression system for many proteins i.e. membrane proteins. 
Although bacterial expression may offer folded and stable recombinant proteins, 
there may still be a lack of important post-translational protein modifications such 
as glycosylation or phosphorylation. These systems and biological machinery 
typically exist in eukaryotic organisms such as yeast, insect, and mammalian cells. 
Insolubility of proteins expressed in bacterial vectors such as C43 has been 
extensively publicised, such as in intrinsically disordered proteins which tend to 
aggregate more than folded proteins. S. cerevisiae is a common species of yeast 
and is one of the most intensively studied eukaryotic model organisms in 
molecular and cell biology much like E. coli cell lines. Currently, there has been no 
substantial research into the expression of the sigma-1 receptor in S. cerevisiae 
cell lines, even though these systems offer high protein yields and sufficient post-
translational modifications. However, a disadvantage of using this expression 
system can be said for the transformation protocol used to incorporate desired 
protein DNA fragments into yeast. This process is often timely and costly in 
comparison to E. coli cell lines as the reagents and transformation incubation time 
differ significantly. 
 
Currently, the most common methods for expressing the sigma-1 receptor is by 
utilising transformation in insect and mammalian cell lines. Both of these systems 
if performed correctly, offer highly stable post-translationally modified desired 
proteins however these expression systems are often prone to contamination 
human error. Furthermore, successfully expressing recombinant membrane 
proteins in insect cells can take up to two months, as it is vital to create a high-
quality viral titre containing a desired bacmid DNA for sufficient insect cell 
infection. Therefore, this project aims to find a suitable expression system for the 
Bradley Hilton 
 pg. 17 
sigma-1 receptor that can be performed in the least amount of time with the 
highest protein yield. 
 
E. coli have been utilised by scientific researchers over decades for the purpose of 
recombinant protein expression. This gram-negative bacterium has become 
highly popular expression platform for heterologous proteins as they have the 
capability of high overexpression levels. In order to express the endoplasmic 
reticulum membrane protein Sigma-1 in E. coli, competent cells should be used. 
E. coli bacterium cells have the ability to incorporate foreign plasmid DNA through 
their cell walls effectively if they have been altered through electroporation or 
with the addition of specific chemicals. We selected the use of C43 competent 
cells as they are highly effective at expressing toxic proteins including membrane 
proteins from many organisms such as; yeast, eubacteria, viruses, plants and 
mammalian cells. These cells have the necessary molecular machinery to express 
desired proteins and enhance its expression as a cellular priority. The process by 
which competent cells take up recombinant DNA for protein expression is known 
as transformation. Prior to this process it was necessary to ensure that a construct 
containing our desired protein was cloned and amplified to create stocks for 
multiple transformation procedures.  
 
 1.6 Introduction To Membrane Protein Solubilisation Techniques 
 
Cellular membranes are complex biological structures that consist of various lipids 
and proteins to ensure cell survival. Many of the proteins that reside on cellular 
membranes form channels or function in cellular signaling transduction pathways 
that are vital for almost all cellular activities. One of the most significant 
challenges scientists have faced when studying these proteins, is being able to 
successfully extract and solubilize whilst maintaining the membrane bound 
biochemical structure. A method that revolutionized the extraction of these 
insoluble proteins is known as detergent extraction. Detergents are soluble 
amphiphiles (i.e. containing both hydrophobic and hydrophilic groups) and are 
currently the most adopted method of membrane protein extraction12. The most 
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common types of detergents used for this extraction can be divided into three 
groups; ionically charged (either anionic or cationic), nonionic (uncharged) or 
zwitterionic (having both polar or nonpolar groups but having a total charge of 
zero)13.   









In a water-based solution, detergents form soluble micelles which consist of a ring 
like formation. Although detergents consist of hydrophobic nonpolar tail groups, 
overall, they have a high level of water solubility enabling efficient extraction of 
membrane proteins. Their outward pointing polar heads are highly hydrophilic 
enabling a complete mixture of these micelles with aqueous solutions.  For this 
particular project we will be using a newly developed detergent called lauryl 
maltose neopentyl glycol (LMNG: chemical formula C47H88O26) along with a 
cholesterol analogue known as cholesterol hemisuccinate (CHS: chemical formula 
C31H50O4) for sigma-1 extraction.  LMNG detergent contains two hydrophobic 
chains of equal length and two hydrophilic polar maltose head groups. In recent 
years, multiple publications have shown the potential this detergent has in 
solubilising difficult membrane proteins and have even demonstrated LMNG to 
be more effective than dodecyl maltopyranoside (DDM). 
Figure 3: Diagram of the basic structure of a micelle with nonpolar 
hydrophobic tail groups. An Overview of Detergent Micelle Formations. 
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Figure 4: Chemical structure of lauryl maltose neopentyl glycol (LMNG) with two 
hydrophobic nonpolar tails and two hydrophilic polar maltose heads15. The 
Chemical Structure of Lauryl Maltose Neopentyl Glycol (LMNG). 
 
The crystal structure of the sigma-1 receptor was identified by Shmidt et al in 2016 
using 01% (w/v) of this detergent supplemented to their extraction buffer. From 
their crystallography data they identified that this detergent had little adverse 
effects to the stability and structure of the protein and managed to successfully 
bind an antagonist compound. As well as solubilising extracted the sigma-1 
receptor with 1% (w/v) LMNG, Shmidt et al also used 0.1% CHS (w/v) 
supplemented to the same extraction buffer. Typically, cholesterol or its 
analogues are often used for insertion into micelles for increased stability of a 
desired protein. Many proteins, especially membrane proteins rely on specific 
lipid interactions to retain correct functions and structure whilst residing in 
biological membranes. For this reason, we intend to supplement our protein 
extraction buffers to the same protocol used by Shmidt et al and use similar 
purification procedures with the addition of the appropriate concentration of 
both LMNG and CHS.  
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Figure 5: Chemical structure of cholesterol hemisuccinate (CHS), an analogue of 
cholesterol16. The Chemical Structure of Cholesterol Hemisuccinate (CHS) 
 
In recent years, there has been a major increase in the funding and research into 
nanodisc technologies in the biotech industry. One of the most notable 
developments in this field was the synthesis of styrene maleic acid copolymer 
(SMA) resins for the purpose of membrane protein extraction. Recently in a 
profound number of publications, it has been demonstrated that solubilised SMAs 
can dissolve biological membrane bound proteins into the formation nanodiscs. 
These nanodiscs have shown to natively solubilise spherical sections of biological 
membranes at varying size and molecular weights. Within these nanodiscs, 
proteins are still physically embedded into their original patch of lipids to which 
they would become functionally active. This is facilitated by amphiphilic polymer 






Figure 6: Diagram of the basic chemical structure of a 1:1 styrene maleic acid 
compound and graphical representation of how SMAs form protein nanodisc 
complexes17. The Formation of SMA Nanodisc Complexes. 
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The Styrene-maleic acid chains result in water based solubilization with an 
increased stability of the extracted proteins. The discovery of SMAs has 
revolutionized the research of many difficult to solubilize membrane proteins and 
many researchers are considering adopting this extraction method over detergent 
based protocols. These SMA nanodiscs can be synthesized in varying ratios of 
styrene to maleic acid groups, which can be catered to specific protein research 
needs or through protocol optimization. For example, the most commonly used 
form of SMAs used for membrane protein structural research, are the SMA 2:1 
copolymer as they have been shown to be highly stable and form low molecular 
weight nanodiscs with a diameter of around 10 to 20nm. For this project we will 
attempt to solubilize the sigma-1 receptor using 2% (w/v) 2:1 SMA copolymer as 
there is currently little to no literature available for this research. Furthermore, 
we will be experimenting solubilization with an SMA copolymer variant known as 
Styrene Maleimide resins (or SMA imides). These positively charged copolymers 
consist of alternating styrene and maleimide moieties which also have been 
demonstrated to effectively extract membrane proteins whilst maintaining a high 









Figure 7: The Two-Dimensional Chemical structure of styrene maleimide (SMA imide) 
copolymer 1:1 resins18. An Overview of a Basic SMA Imide Chemical Structure. 
 
Currently there have been no scientific publications demonstrating successful 
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Although, other studies have demonstrated its effectiveness of extraction such as 
that of G-coupled receptors in various papers. For this project all SMA and SMA 
imide resins will be ordered through Cray Valley supplier in a non-water-soluble 
chemical state. All resins will require a solubilization protocol via protonation in a 
condensation reaction using an appropriate solvent such as hydrochloric acid 
(HCl) or sodium hydroxide (NaOH). Post solubilization, all SMA resin solutions will 
need to be purified and freeze dried to remove any contaminates. For this study, 
we will be using transmission electron microscopy (TEM) in order to identify the 
presence of nanodisc formations within our solubilized sigma-1 samples post 
solubilization and purification.  
 
1.7 NMR Studies for The Identification of The Sigma-1 Receptor 
 
Nuclear magnetic Resonance imaging or NMR has become an increasingly 
important scientific technique for the screening and characterisation studies of 
simple and complex biomolecules. In the last 25 years, NMR along with other 
structural techniques such as crystallography has enabled the identification of 
three-dimensional molecular protein structures on the atomic level. In addition, 
not only can NMR provide high resolution structural information, it also has the 
capability in determining kinetic interactions proteins have in varying 
environmental conditions i.e. in the presence of agonist or antagonist compounds. 
The scientific principles surrounding NMR experiments may differ depending 
upon the study conditions applied and the researcher’s analytical objectives. 
 
However, the physical scientific principles that make NMR possible remain the 
same throughout almost all experiments. The NMR principle is strongly 
dependent upon atomic particle spin theory and many chemists, biologists and 
physicists have used this principle to their advantage. Electrons are subatomic 
particles with the propensity to spin and atomic nuclei also possess this physical 
property. The nucleus of an atom consists of protons and neutrons, which can also 
be broken down to subatomic particles such as quarks.  Neutrons are comprised 
of two quarks (down quarks) with a charge of -e/3 and one quark (up quark) with 
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a charge of +2e/3, which equates to a net neutron charge equal to 0. In contrast, 
the proton consists of two up quarks with a charge of +2e/3 and one down (down 
with a charge of -e/3, resulting in a net positive proton charge of +1. As the 
neutron number plus the proton number are equate to an odd level of charge it 
can be said that they have half-integer spin or ½ spin28.When atoms in elements 
such as H1 and C13 are in ½ spin they are considered to have a low energy state. 
However, when a magnetic field is applied to these atoms, they will begin to 
precess on their spinning axis around the direction of the applied field.  
 
If energy is absorbed by the nucleus of these atoms during this low energy state, 
then they will flip upon the axis opposing the direction of the magnetic field 
applied. This physical property of these atoms at this stage is considered to be a 
higher energy state. In terms of NMR imaging, scientists are often interested in 
the relaxation states of these precessing atomic nuclei to which provides key 
structural information for biomolecules. This relaxation state is underpinned by 
the principles of thermodynamics and studies physical changes when atoms 
transition from a higher energy state to a lower energy state. This shift between 
energy states of these atomic nuclei can be detected by applying a known 
frequency of electromagnetic radio wave radiation. Furthermore, this applied 
radio wave causes an atomic resonance to which can be detected and translated 
into an NMR peak of specific intensity. In relation to our NMR studies for this 
project we performed a 1D proton NMR study and preformed a Carr-Purcell-
Meiboom-Gill (CPMG) experiment. 
 
These studies focussed on identifying the interactions between a known agonist 
compound fluoxetine hydrochloride and the sigma-1 receptor. The first of our 
NMR experiments involved the running of CPMG sequences on the individual 
samples and then creating an overlay for quantitative analysis. This type of NMR 
experiment is often referred to as relaxation editing, and in recent years this 
technique has been increasingly used to assess the binding affinities of proteins 
and their ligands. This experiment depends on the principle that rotational 
tumbling is proportional to the molecular size of any given protein, i.e. higher 
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molecular weight proteins have a longer rotational time than that of lower 
molecular weight proteins. Subsequently, this means smaller proteins will have 
shorter T2 relaxation times (resulting in broader peaks) than that of larger 
proteins. In principle, CPMG experiments measure the T2 relaxation time of 
proteins, by monitoring the signal decay as a proportional unit of relaxation 
delay29. This allows for the analysis of peak intensities, by measuring their width 
and height for ligand-protein interactions. 
 
In addition, this experiment requires control samples to compare spectra in both 
the presence and absence of target proteins in solution. Hence, the presence of 
multiple overlay signals for varying sample conditions in our spectra for this 
experiment. Once we obtained data for the CMPG experiment it was deemed 
necessary to determine whether the detergent used to solubilise our target 
protein was also binding to the agonist ligand. For this we run a normal 1D NMR 
proton spectrum on the same samples to also assess for the presence of peak 
shifts and changes in peak intensities30. Although, these experiments do not 
provide us with KD values or other pharmacological binding affinity data they serve 
as an effective method at determining protein interactions. Currently, fluoxetine 
hydrochloride along with other selective serotonin reuptake inhibitors (SSRI’s) 
have been previously identified in publications, as having affinity for the sigma-1 
receptor. Therefore, this final experiment served as a valuable early confirmation 
technique for the isolation of our target protein by measuring its interactions with 
a known agonist of the receptor. 
 
1.8 Project Aims and Objectives 
The sigma non-opioid intracellular receptor 1 is a notoriously difficult protein to 
successfully solubilize and express in prokaryotic systems such as E. coli cell lines. 
There have been very few studies that have demonstrated a successful and 
optimized purification procedure for this chaperone protein in yeast and E. coli 
cell lines. Furthermore, this project aims to produce optimized growth and 
purification procedures for the sigma-1 receptor in C43 E. coli and INVSc1 S. 
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Cerevisiae cell lines, as previous studies have focused on using advanced cell lines 
such as insect Sf9 cells. The rationale behind this is due to advanced expression 
systems, such as insect and mammalian cell lines often requiring timely growth 
procedures and tend to produce low yields of target proteins. Whereas E. coli 
systems, when optimized can produce much higher protein yields. In addition, 
studies that have successfully solubilized the sigma-1 receptor with the aid of 
cationic and non-cationic detergents which are very costly and can often affect 
the structural integrity of the protein during purification. 
 
Furthermore, this project is going to analyze and compare the effectiveness of 
detergent based methods for membrane solubilization against that of newly 
developed techniques, such as nanodisc technology in the form of SMAs or SMA 
imides. Currently, there are no known publications that have studied agonist or 
antagonist compound interactions with the sigma-1 receptor when natively 
solubilized in nanodiscs. For this reason, we aim to produce a successful isolated 
sample of the sigma-1 receptor solubilized by nanodisc technologies or via 
detergent based methods. Once these sample have been acquired, the ultimate 
objective is analyzing the interactions a known agonist; fluoxetine has with our 
desired protein using 1D proton nuclear magnetic resonance (NMR) imaging 
experiments. These experiments will not focus on the analysis of the proteins 
structure itself, however we will be analyzing the interacting drugs peak 
intensities in the presence or absence of the sigma-1 receptor. This project will be 
comparing the similarities and differences to past publication results such as that 
of the 2016 Crystal structure of sigma-1 by Shmidt et al. Although, this study 
focused on the expression of sigma-1 receptor in insect expression systems it 
serves as a valuable reference for this project as we will be using similar 
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Research Project Aims 
 
• Successfully produce a modified pcold-1, transformed C43 cell line 
containing a DNA fragment for the sigma-1 receptor tagged to green 
fluorescent protein (GFP) 
• Compare transformation procedure in C43 cells with transformed INVSc1 
Saccharomyces cerevisiae containing the sigma-1 LEU2 construct 
• Create bacteriological and yeast growth cultures that are induced at an 
optimum OD600, for sufficient cell culture density of C43 and INSVc1 
• Extract the sigma-1 receptor tagged to GFP via solubilisation techniques 
such as detergent based and native nanodisc technology 
• Successfully purify solubilised sigma-1 receptor and isolate via TEV 
protease cleavage from GFP  
• Confirm isolation through antibody screening techniques such as western 
blot  
• Once isolation is deemed successful use NMR studies to assess the sigma-
1 receptor interactions with known agonists such as fluoxetine 
hydrochloride  
• Assess retrieved NMR data to draw conclusions between solubilisation 
techniques for the sigma-1 receptor 
• If all aims are reached to the correct deadlines, then we will attempt to 
express the sigma-1 receptor in Sf9 insect cells to compare and correlate 
expression results  
 
1. Materials and Methodologies  
2.1 Preparation of SMA And SMA Imide Nanodiscs For Solubilization 
As both the SMA and Imide nanodiscs from stock supply resided in a water 
insoluble state it was necessary to solubilize them via a condensation reaction. 
SMA resins are soluble in water at basic pH so it was necessary to first perform 
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solubilization via deprotonation using sodium hydroxide (NaOH), whereas SMA 
Imide resins are soluble in water at acidic pH therefore required protonation using 
hydrochloric acid. For this study we ordered the stock resins of SMA 2000 (2:1) 
and SMA imide 1000I (1:1) from the supplier Cray Valley18. These resins can 
chemically alter depending upon the ratio of styrene to either maleic acid or 
maleimide groups (i.e. one styrene group for one maleimide group). The protocol 
for solubilizing these resins were conveniently provided for the supplier, however 
we made modifications due to equipment and reagent availability.  
 
Table (1): Copolymer resin chemical properties supplied by Cray Valley19 
Ratio of styrene 
to maleic acid or 
maleimide 
Copolymer Name Mn (g/mol) Mw (g/mol) Kilodaltons (KDa) 
2:1 SMA 2000I 2,700 7,500 7.5 
1:1 SMA IMIDE 1000I 2,000 5,500 5.5 
 
In order to solubilize these resins, it was necessary to determine the volume of 
hydrochloric acid or sodium hydroxide required for this procedure. All of these 
values were supplied by Cray Valley and it just required equation substitution. 
 
Equation 1: Calculation of NaOH volume for SMA 2:1 (SMA 2000I) Solubilization 
 
 mL of NaOH = (amine or alkali mol. wt.) (SMA acid no.) (wt. SMA) (excess factor) 
 
56,100 X (amine or alkali concentration, as a decimal) 
 
In equation 1, we find the method used to determine the volume of NaOH to 
solubilize our SMA 2:1 (SMA 2000I) resins. The ‘amine or alkali mol. wt.’ equated 
to the molecular weight of NaOH (40mw), the ‘SMA acid no.’ of this calculation 
was 350, the ‘wt. SMA’ was the weight of the resin used and the excess volume 
of NaOH to solubilize the resins equated to the ‘excess factor’, which is typically 5 
to 15% expressed as a decimal i.e. 1.1. This figure from equation 1, was then 
divided by 56, 100 multiplied by the concentration of NaOH as a decimal. For our 
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SMA 2:1 solubilization protocol we determine that 1M NaOH would be enough to 
solubilize our pure copolymer resin. Once we had made this calculation it was then 
necessary to grind these resins down to a smooth powder base to maximum the 
surface area to volume ratio of the reaction. Following this, the powdered SMA 
2:1 resin was then added to the 1M NaOH solvent within a boiling flask20.  
 
A magnetic stirrer was then added to the boiling flask and the solution was gently 
stirred under reflux conditions for 2 hours at 60°C, using heated bumping granules. 
Once the reaction time duration was complete, the solution was removed from 
the heat source and left to cool down to room temperature. After this, the 
solution was then precipitated using a 1 M HCl solution to achieve pH.5 for the 
wash phase. Post precipitation, the precipitate was washed for 5 wash cycles using 
Milli-Q water. The precipitate suspended in Milli-Q water was then centrifuged at 
11,000g using a BeckmannTM J-25 centrifuge (JA-10 rota) for 15 minutes per cycle. 
Following the wash phase, the precipitated resin was then resuspended in 0.6M 
NaOH to achieve pH 8.0. Once the desired pH was achieved the precipitate was 
placed in an orbital shaking incubator set to 25°C and at 180rpm for overnight resin 
dissolvement. Once the SMA 2:1 resin was assessed for complete resuspension, it 
was then flash frozen using liquid nitrogen and set up for lyophilises for 1 to 2 
days. The freeze dried solubilised SMA 2:1 resin was then weighed out into 













































Figure 9: Demonstrates SMA imide 1000I solubilisation rationale with 
the aid of HCl via a ternary amine protonation. Chemical Equation of 
SMA Imide 1000I Solubilisation. 
Figure 8: Demonstrates SMA 2000I solubilisation rationale with the aid 
of NaOH deprotonation and HCl protonation. Chemical Equation of 
SMA 2000I Solubilisation. 
HCl 
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Equation 2: Calculation of HCl volume for SMA Imide 1:1 (SMA 1000I) 
Solubilization 
mL of HCl = (SMIwt)(SMAIndex)(HClmw) (Excess Factor) 
1000 (Acid concentration) 
In equation 2, we find the calculation used to determine the volume of 
hydrochloric acid for solubilising the SMA imide 1:1 resin. From the equation, the 
‘SMI wt.’ equates to the total weight of SMA imide resin used in the reaction, the 
‘SMI index’ for the SMA 1:1 imide resin used in this protocol was 3.13, the ‘HCl 
mw’ is the molecular weight of hydrochloric acid i.e. 36.45 mw, the ‘excess factor’ 
corresponded to the excess volume of acid used to completely solubilise the resin, 
and was expressed as a decimal. Finally, this figure was then divided by 1000 times 
the concentration of acid in the reaction. Just as in the SMA 2:1 solubilisation 
reflux reaction, the SMA imide 1:1 resin was weighed out for solubilisation using  
1M HCl.  
 
The solution was then refluxed for 2 hours at 60°C under reflux conditions until the 
resin was completely dissolved. Following this, the dissolved resin was then left to 
cool down to room temperature and then prepared for pH adjustment using 5M 
NaOH. The dissolved SMA imide 1:1 resin was then adjusted to pH 7.5 and then 
prepared for flash freezing using liquid nitrogen. Upon the flash freezing of the 
dissolved resin, it was the lyophilised for 2 to 3 days to ensure complete removal 
of any moisture from the soluble SMA imide dried reagent. The newly solubilised 
SMA 1:1 imide was then weighed into 5g aliquots and stored at room temperature 
until required for use. For our solubilisation techniques these resins were used at 
2% (v/w) of the total cell lysate volume. Currently this supplemented 
concentration of solubilised SMA or SMA imide resins has been recommended by 
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2.2 C43 Expression Protocol for Isolated Sigma-1 
In order to insert a suitable construct to transform into C43 cells we firstly ordered 
the human SIMGA1 gene incorporated with a N-terminus super folder green 
fluorescent protein gene sequence. Separating these two proteins was a TEV 
cleave site enabling for late stage sigma-1 isolation during purification. In addition, 
the N-terminus was designed to obtain the necessary tags required for 
purification, including twin Step tag and 6xHis tag. The sigma-1 gene was then 
inserted into a modified version of the p-Cold1 Vector using a transformation 
procedure into DH5alpha cells. These cells were then used to create an overnight 
starter culture in LB medium, at 37°C in a shaking incubator at 180rpm. The 
overnight starter cultures were then centrifuged at 13,000rpm for 10 minutes to 
obtain the cellular pellet. The pelleted cells then underwent DNA extraction for 
isolation of the desired construct in Milli-Q water. The extracted DNA sample was 
then sent for sequencing to ensure the Sigma-1 gene was correctly inserted into 
the modified p-Cold1 vector. Once the correct sequence of the final construct was 
confirmed, it was then possible to move forward to expression of our desired 
recombinant protein. In Figure 10, It is possible to see the final sequenced 


















2.3. Final Construct Design Rationale  
 
Figure 10: Sigma-1 Final Construct of The Modified p-Cold1 Plasmid (5873 Base Pairs. 
Image Obtained from SnapGene Software. Final Sigma-1 Modified p-Cold1 Construct. 
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The final construct was designed to be highly suitable for both the expression of 
Sigma-1 and its characterization. The green fluorescent protein tag for the Sigma-
1 was implemented to ensure easier screening for the protein post induction and 
during purification steps. We decided we could do this by measuring the GFP 
fluorescence of our samples at different timepoints of the study, whether that be 
during size-exclusion chromatography (SEC) or via a fluorescent plate reader at 
any time. On the N-terminus of the GFP, a twin Step tag was implemented for the 
purpose of one-step purification of the recombinant protein. The twin-step tag 
(amino acid sequence: SA-WSHPQFEK-(GGGS)2-GGSA-WSHPQFEK) is a short 
peptide that has a molecular weight of 6.98KDa. Many publications have 
demonstrated this tag to be extremely useful as it combines a high specificity and 
high affinity for Strep-Tactin beads during purification. This makes it possible to 
even to perform complete affinity chromatography from a cell culture 
supernatant, reducing the time spent on additional purification steps. The 
polyhistidine tag adjacent to the twin-step tag also serves as an effective method 
of purification for Sigma-1. The 6XHis tag is a small peptide consisting of 6 
Histidine amino acids (CATCATCATCATCATCAT) and has a small molecular weight 
of 840.9 Da.  
 
The purpose of implementing this tag was for having the ability to perform 
immobilized metal affinity chromatography (IMAC) on Sigma-1 extract samples. 
The principle of the His tag purification is since histidine residues chelate metal 
ions such as nickel under specific conditions causing them to bind to one another. 
This makes it possible to elute desired proteins by using compounds such as 
imidazole to compete binding with the His tag for the charged metal ion resin thus 
eluting a specific protein in a single sample. When screening for the target protein 
it is important to take into consideration the final molecular weight of the 
expressed complex including all the molecular weights of all tags. We estimated 
our final Sigma-1 tagged GFP complex to be around 55KDa and we decided to 
screen samples that contained proteins around this molecular weight. For the 
expression of Sigma-1 it was necessary to select a cell line that is highly 
competent, has the ability to express toxic proteins and at high levels. For this 
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stage we selected the OverExpressTM C43 (DE3) Electrocompetent cell line 
supplied from Sigma Aldrich. This strain is derived from C41 (DE3) cells by selecting 
colonies resistant to the expression of toxic proteins. These cells were stored at -
80°C until they were required for use during a transformation procedure. In recent 
years, this cell line has received a high level of recommendation for the expression 
of membrane proteins throughout various expression system publications. 
 
2.3 Methodology for C43 Electrocompetent Cells Transformation 
Once all the pre-study requirements had been reached and the Sigma-1 construct 
had been successfully sequenced it was then possible continue forward onto the 
transformation stage. Transformation is a multistep process which includes a heat 
shock process to increase competent cell wall permeability along with a 
temperature specific incubation period suitable to the cells being used. However, 
prior this procedure the electrocompetent C43 cells must undergo a growth 
process using nutrient rich agar medium with the addition of ampicillin for 
selective growth. The Sigma-1 modified Pcold1 construct incorporates an 
ampicillin resistance gene (AmpR) to ensure the required C43 cells will specifically 
grow without undesired contamination. Prior to the transformation procedure 
selective agar plates were prepared in order to ensure a level of organization 
during the process. In order to make these selectivity Agar plates it was necessary 
to prepare both antibiotic and Luria Broth medium stocks.  Ampicillin sodium salt 
was used to prepare stocks of 100mg/mL in Milli-Q water.  
 
Following the preparation of the antibiotic stocks it was necessary to prepare Luria 
Broth Agar as it is vital for preparing the selectivity plates. Once this was complete, 
it was necessary to adjust pH of the LB-Agar to 7.5 as it is the optimum for C43 
cells. The medium was then autoclaved for 15 minutes at a temperature of 121°C 
using a Prestige 2100 Classic autoclave. The sterile autoclaved medium was then 
cooled down to 50°C using a water bath as the addition of ampicillin to medium at 
higher temperatures can lead to degradation of the antibiotic. Once the LB-Agar 
medium had cooled to the optimum temperature, under aseptic conditions we 
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dispensed the ampicillin to the medium to create a final concentration of 
100ug/mL. Following this the molten LB-Ampicillin Agar was poured into each 
petri dish and then left at room temperature to solidify. Once the medium had 
solidified stocks of the LB-Ampicillin Agar plates were completely sealed and then 
stored at 4°C in a fridge for later use. 
 
After all the necessary preparations were complete, it was then possible to start 
the transformation procedure using the Sigma-1 modified pCold1 construct and 
C43. During this procedure, a 1mL stock of electrocompetent C43 cells and a 50µl 
stock of the Sigma-1 construct (102ng/µl) was removed from the -80°C and thawed 
on ice for 15 to 20 minutes. Following a single thaw cycle, 2µl of the Sigma-1 
construct was gently mixed with competent C43 cells and then placed back on ice 
for a further 15 minutes. Once the mixture had been incubated on ice, the Sigma-
1 construct and C43 cell mixture underwent a heat shock procedure in a water 
bath at 42°C for 45 seconds. Post to the heat shock procedure the transformation 
mixture was then incubated back on ice for a further 15 minutes. Following the 
incubation on ice, the mixture was then supplemented with LB medium without 
the addition of ampicillin. The transformant suspended in LB medium was then 
transferred to a shaking incubator with a temperature of 37°C and rotation speed 
of 250rpm for 1 hour. Following the required incubation time, the transformant 
mixture was then aseptically plated onto the LB-Amp Agar selectivity plates 
previously prepared. During this procedure the transformant mixture was 
suspended onto a single selectivity plate and a sterile loop was used to inoculate 
the entire surface area of the LB-Amp Agar medium. Furthermore, the newly 
inoculated plate was then completely sealed, inverted and placed in an incubator 
overnight at 37°C. 
 
2.4 Transformation Plate Screening and Preparations for Growth 
At 12-24 hours following the incubation of the transformation culture, the plate 
was screened for viable colonies to ensure sufficient growth of the transformed 
C43 cells had occurred. As these selectivity plates contained a sufficient 
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concentration of ampicillin, it was decided likely that isolated colonies were 
probable to have incorporated the Sigma-1 construct containing the AmpR gene. 
Prior to the preparations of large-scale growth, it was necessary to store the C43 
selectivity plates at 4°C post removal of the incubator used overnight. In order to 
ensure the large-scale growth protocol was followed with efficiency it was vital 
that all reagents including the growth medium was prepared prior to the protocol. 
During the large-scale growth protocol, it was decided to be beneficial to use an 
increasingly nutrient rich medium to maximise cellular density and protein 
expression. For this we adopted the use of terrific broth (TB) as an effective 
medium source for our transformed C43 cells. Prior the growth we estimated that 
4 litres of terrific broth should be enough to harvest enough cells for screening for 
our target protein. Typically, terrific broth medium has the addition both mono 
and dibasic phosphates (such as dipotassium hydrogen phosphate and potassium 
dihydrogen phosphate).  
 
However, this is usually used to increase the yield of plasmid DNA in suspension 
of derived C43 cultures, nonetheless for our specific study we deemed this as 
unnecessary. In order to make a single litre of terrific broth medium. The pH of 
the terrific broth mixture was then adjusted to 7.5, just as the LB-Amp Agar was 
previously. The mixture was then autoclaved in a sterilised 1L growth flask for 15 
minutes at 121°C. In order to maximise the overexpression of our target protein it 
was vital that we carried out an induction procedure at a specific point of the C43 
cell’s exponential growth phase. As described previously, the Sigma-1 modified 
pCold1 construct holds the LacI promoter gene and can be activated with the 
addition of the reagent IPTG. Prior to the setup of the large-scale growth it was 
also necessary to prepare stocks of IPTG at the correct concentration required for 
our induction protocol. We prepared a stock solution of 1M and stored these at -
20°C for later use.  
 
Once all of the required reagents and medium were correctly prepared it was then 
possible to continue setting up the large-scale growth. In order to achieve a 
minimum cellular density of 6.4 x 108 during growth, we needed to inoculate the 
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medium with a starter culture to reach this level. A starter culture was prepared 
by inoculating four separate starter cultures per litre of TB medium. Each starter 
culture contained LB-Amp medium in a sterile falcon tube and was inoculated with 
a single colony selected from the C43 transformation plate using a sterilised 
pipette tip. The starter cultures were then transferred to a shaking incubator 
overnight, set to 37°C at 180rpm. After 12 to 24 hours of growth, the starter 
cultures could be used to inoculate 4L of terrific broth medium for our large-scale 
growth phase. Prior to this transfer a 1mL blank sample was taken from the 
sterilised TB medium for a baseline, for the purpose of tracking the optical density 
(OD) for each 1L of inoculated TB medium.  
 
Once the TB medium had been inoculated with the starter cultures, they were 
then transferred to a shaking incubator set to 37°C at 180rpm. The OD of each flask 
was measured every 30 minutes using a DiluCell 20 device and all data was 
recorded electronically. During the large-scale growth it was important to induce 
the culture once the peak of exponential growth had been reached i.e. OD of 0.8 
to 1.0 600nm. This was implemented to maximize cell harvesting and to avoid cells 
entering the death phase of growth. After 180 minutes of culture incubation the 
average OD equated to 1.12 (8.96 x 108) at 600nm and we decided to induce all 4 
liters of growth. As we used the Sigma-1 Modified pCold1 construct it was useful 
to follow a cold shock induction system for maximizing the overexpression of our 
target protein. This procedure aims to slow cellular growth during protein 
induction, reducing the formation of protein aggregation thus minimizing the 
development of inclusion bodies.  Once the sufficient OD had been reached, the 
cultures were removed from the shaking incubator and placed on ice for 15 
minutes. During this time the temperature of the shaking incubator was reduced 
to 15°C and IPTG 1M stocks were left at room temperature to thaw. Once the 
cultures were incubated on ice for the specified time, they were then induced 
using a final IPTG concentration of 1mM. The induced cultures were then placed 
back in a shaking incubator set to 15°C and 180rpm overnight for 12 to 24 hours. 
Following the correct culture induction time, the 4L culture was then centrifuged 
using a Beckman Centrifuge and a T45i rota for 25 minutes at 6,000rpm. The 
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supernatants containing the terrific broth medium was discarded and the cellular 
pellets were placed on ice for resuspension in lysis buffer.  
 
The chosen lysis buffer changed throughout the study due to optimisations in our 
protocol, we firstly started using 1x tris-buffered saline (TBS) at a pH of 7.5. 
However, as we had issues with solubilisation of our protein, we decided to use 
the same sample buffer used by Schmidt et al who were the first to confirm the 
true crystal structure of the Sigma-1 receptor. This buffer consisted of 20mM  
HEPES, 250mM NaCl, and 20% glycerol (v/v) also at pH 7.5. Depending upon the 
solubilisation technique used for Sigma-1, the lysis buffer was modified and 
supplemented with a specific reagent i.e. detergent. 
 
The previously centrifuged cellular pellets incubated on ice were then 
resuspended using HEPES-buffered saline lysis buffer and then supplemented 
with HaltTM protease inhibitor single-use cocktail 100X (EDTA free). At this point a 
reference sample was taken from the cell lysate and stored at 4°C for later 
screening of our target protein and its tag i.e. GFP fluorescence and SDS-PAGE. 
Once the cell lysate had been supplemented with a protease inhibitor, it was then 
possible to continue through to extracting Sigma-1 through a protocol consisting 
of sonication, ultracentrifugation, homogenisation and nanodisc incubation. The 
30mL cell lysate was then placed in a sterile volumetric beaker and then placed 
back on ice during the sonication procedure. During this protocol the cell lysate 
was sonicated at 20 kHz using a Soniprep 150 for 15 split cycles at 15 minutes.  
This technique ensured that the cell lysate was sonicated for 30 seconds at the 
specified amplitude, and then incubated on ice for a further 30 seconds in one 
complete cycle.  
 
The sonicated cell lysate was then ultracentrifuged using a Beckman Optima LE-
80K centrifuge with a T70ti rota. The sonicated lysate was centrifuged for 1 hour 
at 45,000rpm to obtain pelleted cellular membranes and to discard undesirable 
cellular debris.  Following this, the pelleted membranes were then resuspended 
on ice using the same lysis buffer and homogenised using a micro grinder ensure 
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complete protein extraction. The sample was then supplemented with 2% (w/v) a 
SMA or SMI previously prepared reagent and the cell lysate was then mixed 
overnight at 4°C for solubilised membrane extraction of Sigma-1. After 12-24 hours 
of solubilisation, the cell lysate was further centrifuged at 45,000rpm using a LE-
80K with a T70ti rota to isolate the supernatant. Post centrifugation the 
supernatant was immediately extracted and placed on ice. In contrast, the 
pelleted membranes were resuspended in lysis buffer and flash frozen in liquid 
nitrogen for later screening if Sigma-1 extraction was poor. As previous nanodisc 
studies had demonstrated that free disc formations in solution can interfere with 
IMAC purification, we decided to perform a dialysis procedure to remove any free 
nanodiscs.  
 
2.5 Purification Techniques for Nanodiscs Solubilised Sigma-1 GFP Complexes 
The dialysis of solubilised Sigma-1 was set up immediately following extraction of 
the supernatant. A total of 4 L of HEPES-buffered saline was prepared prior to this 
procedure and stored at 4°C. The extracted supernatant was then inserted into a 
sealed 10K MWCO SnakeSkinTM dialysis tubing to be suspended into the 4L of lysis 
buffer for 12-16 hours overnight. In addition, the dialysing supernatant was slowly 
spun using a magnetic stirrer at 4°C to prevent aggregation and the precipitation 
of sigma-1 out of solution. Once the sample was dialysed for the specified time, it 
was then vital at this stage to take a reference sample that could be used for 
performing screening techniques such as SDS-PAGE, in gel-fluorescence and GFP 
fluorescence microplate reading.  
 
2.6 Primary Purification: Immobilised Metal Affinity Chromatography  
As the free SMA or SMI nanodiscs had been removed from the solubilised sigma-
1 supernatant, it was then possible to purify our desired protein using IMAC. This 
procedure was performed using the automated AKTATM start chromatography 
system in a series of specific protocol phases. Prior to this procedure a 5mL 
HisTrapTM HP nickel charged column was fitted to the system, so that the sample 
could be passed directly through its flow path. During the first phase of this 
purification, double distilled water (ddH2O) was firstly filtered and degassed to 
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eradicate contaminates and globules. The ddH2O was then run through pump A 
at 0.5mL/minute for three column volumes (15mL) in order to complete the 
primary wash phase of IMAC procedure. 
 
 The confirmation end point of the primary wash phase was determined by 
analysing the reduction and stability of the UV (AU 280nm) and conductivity (S/m) 
sensors. Shortly following this wash phase, the AKTATM system including the 5mL 
HisTrapTM HP nickel column was equilibrated in buffer A. It was important that 
Buffer A was identical to that of the sample buffer in order to promote an affinity 
reaction between the polyhistidine tag and nickel ions of the column. For this 
reason, five (25mL) column volumes of filtered buffer A (1x HEPES-buffered saline) 
was passed through the system at a flow rate of 0.5mL/min. Once both the UV 
and conductivity detectors were stable it was then possible to pass the sigma-1 
sample through the system at 0.5 mL/min on ice and collect its flow through from 
the buffer outlet. At this stage, the analysis of increased UV and conductivity was 
a priority as it enabled us to determine whether a high concentration of proteins 
were in present in our sample. In principle Sigma-1-GFP nanodisc complexes 
should remain bound to the affinity resin via his-tag interactions and undesired 
cellular components should pass through to the flow through collection on ice. 
Following the collection of the flow through sample on ice, it was necessary to 
perform a secondary wash procedure in buffer A to remove any unbound 
contaminants in the IMAC system. During the secondary wash phase 5 column 
volumes (25mL) of buffer A were passed through the system and a secondary flow 
through sample was collected on ice for later analysis.  
 
To ensure that the secondary wash phase was sufficient it was necessary to 
confirm that both UV and conductivity sensor data decreased to baseline levels, 
as this would enable easy identification of potential sigma-1 elutions. In order to 
elute potential desired protein, it was necessary to use a secondary buffer known 
as buffer B. This buffers composition was identical to buffer A, (1x HEPES- buffered 
saline) however it was supplemented with a His-tag competing reagent known as 
imidazole. This buffer was supplemented with 500mM of imidazole and adjusted 
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to the desired pH of 7.5. Following the correct preparation of buffer B, a 
concentration gradient of buffer A and B was set up with a final target 
concentration of buffer B of 100%. A mixture of both buffers with an increasing 
concentration of buffer B was passed through the column at a flow rate of 0.5 
mL/min until the final target concentration was achieved.  Over ice, 4mL elutions 
were collected until UV and conductivity levels decreased to baseline levels. 
Lastly, a final wash of ddH2O was applied to the system and its flow through was 
collected to ensure all possible elutions of sigma-1 were extracted from the 
system. All samples after collection from IMAC purification were then stored at 
4°C until they were used for screening purposes. This was to ensure the stability of 
our target protein and to minimise the possibility of protease cleavage during 
storage. Before going further into other phases of our purification protocol it was 
necessary to screen these elutions for our desired protein.  
 
2.7 SDS-PAGE Sigma-1 Screening Procedure Post IMAC Purification 
In order to do so, all elutions were tested on an SDS-PAGE gel (12% acrylamide). 
To perform this procedure, samples were prepared prior to gel loading in sterile 
eppendorf tubes. For this, 20μl of each elution was supplemented with 4μl of a 5X 
sample loading buffer. The SDS-PAGE gel was then placed into an electrophoresis 
tank and submerged in a 1X Tris-base running buffer at 8.3 pH. Succeeding this, 
10μl of PageRulerTM protein ladder (5 to 250 KDa) was loaded into the first well of 
the SDS gel followed by 10μl of the preprepared samples in ascending order of 
IMAC elutions. The SDS-PAGE was then run at 200 volts (V) for 30 to 45 minutes 
until denatured proteins run down the gel 70 % to 90%. After analyzing the SDS-
PAGE of eluted fractions we speculated that our desired protein could potentially 
be present in elutions T7 to T17 based upon the evidence of bands at 50KDa to 
70KDa. At this stage we decided it was possible to then move forward into an 
additional purification procedure in order to separate these proteins by their size 
and molecular weight. This procedure is known as size-exclusion chromatography 
(SEC) and required us to concentrate these elutions into a single sample. 
Furthermore, samples T7 to T17 were spin concentrated using a 10KDa spin 
column at 4,000rpm, in a Beckman tabletop centrifuge. For our protocol we 
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concentrated these samples down to 500μl as the injection loop we would later 
be using has a total volume of 500μl. In addition, prior to this procedure the 
concentrated sample was centrifuged at 13,000g using a tabletop centrifuge and 
syringe filtered using a 0.22μm filter into a clean 1.5mL eppendorf tube. 
 
2.8 Size Exclusion Chromatography (SEC) Procedure for Sigma-1 Isolation  
 
This procedure was performed at 4°C in a controlled temperature environment to 
prevent protein aggregation and cleavage.  In addition, this semi-automated 
procedure would be aided with the activation of UV detectors set to 280nm (AU) 
and FLD fluorescence detectors set to an excitation of 495nm and emission of 
509nm.  This setup would enable us to detect sigma-1 GFP tagged nanodisc 
complexes as it would enable us to prioritise aliquot fractions that have high 
resolution signals for protein absorbance at 280nm and GFP’s specific detectable 
wavelengths. The first phase of this procedure was performed by introducing a 
wash phase of the SuperdexTM 200 25mL size-exclusion chromatography column. 
Just as seen in the IMAC procedure using HisTrapTM nickel affinity column, the 
SuperdexTM 200 25mL column was washed for one column volume at 0.5mL/min 
in degassed and filtered DDH2O. Following this wash phase, it was necessary to 
perform a subsequent equilibration phase, using the sample buffer for a total 
volume of one column volume. Just as in the IMAC purification, 1x HEPES-buffered 
saline at pH 7.5 was run through the system at 0.3mL/min to ensure protein 
stability and solubility during this SEC phase. Upon the passing of buffer to reach 
a total volume of one column volume, the sigma-1 tagged GFP SMI or SMA 
nanodisc sample was centrifuged at 13,000g using a Beckman tabletop centrifuge 
for 10 minutes to remove any aggregates or debris contaminant.  
 
The 500μl SEC injection loop was then washed with 500μl of ddH2O and 
subsequently equilibrated using 500μl of the equilibration buffer in preparation 
for sample injection. The previously concentrated 500μl sample was then injected 
into the SEC injection loop and the systems flow path was set to flow through the 
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injection loop. During this column phase a flow rate of 0.5mL/min was 
implemented, and dispensed fractions were set to a total volume of 500μl per 
sample on the fraction collector. After one column volume of collection, samples 
were immediately transferred to storage at 4°C to ensure sample integrity. After 
analysing the SEC systems generated data for UV and Fluorescence detectors, 
specific samples were nominated for screening to identify whether these samples 
contained our desired protein. Following the complete run of the SEC purification 
procedure all data was analysed in order to determine which fractions were most 
likely to contain our desired protein. As seen in figure 28, we screened all fractions 
that met the criteria of both high UV 280nm absorbance readings as well those 
that have a high signal for GFP fluorescence. In addition, the resolution of the 
peaks was used as a valuable indicator during this procedure as discrete narrow 
peaks can indicate that a protein at a specific molecular weight and size is eluting 
through a low sample volume. Furthermore, if it was evident post SDS-PAGE 
screening that these fractions have no indications for sigma-1 GFP tagged 
nanodiscs then all the other likely fractions would be exhumed.  
 
Following SDS-PAGE analysis fractions likely contain sigma-1 GFP tagged 
nanodiscs were spin concentrated into one sample using a 10KDa spin column at 
4,000rpm in a BeckmanTM tabletop centrifuge.  The concentrated sample was then 
prepared for TEV cleavage in order to isolate sigma-1 from its GFP counterpart. In 
order to perform this procedure 1mL stocks of TEV protease expressed in C43 cells 
were thawed on ice for 15-20 minutes before being dispensed into the 
concentrated sigma-1 GFP tagged sample. In addition, enough TEV stocks were 
thawed in order to reach a target ratio to protein of 1:100 (w/w) or 10,000 unit 
(1mg) and this depended upon the total volume of concentrated sample. Typically 
for a TEV protease cleavage procedure the sample was concentrated to 10mL-
20mL and incubated on ice before dialysis. Following the dialysis procedure 
previously described, 4L of 1x HEPES-buffered saline at pH 7.5 buffer was 
prepared prior to TEV incubation. Using a 10KDa SnakeSkinTM dialysis membrane 
the concentrated sigma-1 sample was inserted along with the required volume of 
TEV protease stocks. Subsequently after the dialysis membrane insertion, the 
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cleavage procedure was incubated at 4°C and slowly spun using a magnetic stirrer. 
After 12-16 hours of incubation the potentially cleaved sigma-1 sample was 
removed from dialysis and immediately placed on ice for further IMAC 
purification. As we theoretically had cleaved sigma-1 from its GFP tag using the N-
terminus TEV cleavage site 5’CTGGAAGTACAGGTTTTC3’ this would also equate to 
the removal of the His-tag from the sigma-1 complex.  
 
Therefore, the procedure for this IMAC purifications protocol would differ in 
comparison to the previously used method for primary purification. Using the 
procedure previously described for using the AKTATM start affinity nickel 
purification system a primary wash, equilibration, sample loading, secondary 
wash and elution phase were all implemented accordingly. However, for this 
protocol, we expected isolate sigma-1 to elute during the sample loading phase 
as flow through instead of binding to the 5mL HisTrapTM nickel column. In addition, 
we also anticipated sigma-1 to elute during the secondary wash phase as there 
could be potentially some remaining inside the system during sample loading 
phase. In theory both GFP and the TEV protease were expected to remain bound 
to the nickel column as both these proteins have been designed to have a N-
terminus His-tag. As the SDS-PAGE indicated that the flow through sample could 
potentially contain cleaved sigma-1, free GFP or TEV protease it was necessary to 
perform an antibody assay (i.e. ELISA) or a western blot to confirm that the protein 
seen is cleaved sigma-1.  
 
 
2.9 Detergent Solubilisation Methodology for Sigma-1 Isolation 
 
All procedures for transformation, induction and large-scale growth of C43 cells 
were followed to the same protocol and standards as described previously. The 
point at which the protocol for protein extraction and solubilisation alters post 
the centrifugation of the large-scale growth phase. In order to solubilise sigma-1 
with LMNG and CHS it was important to prepare the extraction buffer prior to 
sonication, homogenisation and ultracentrifugation. Once the entire 4L of C43 cell 
growth culture had been centrifuged at 6,000rpm for 25 minutes using a 
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BeckmanTM centrifuge (T45i rota), the supernatants were discarded, and pellets 
resuspended in extraction buffer. The extraction buffer consisted of the following 
reagents; 1% LMNG (w/v), 0.1% CHS (w/v), 1x HEPES-buffered saline. Using this 
buffer, the pelleted culture was resuspended in 50mL of extraction buffer and 
supplemented with 500µl of HaltTM protease inhibitor single-use cocktail 100X 
(EDTA free) per 10mL of cell lysate. 
 
Following pellet suspension, the cell lysate was then prepared for sonication just 
as previously described when using SMI & SMA nanodiscs for solubilisation. 
Following sufficient cycles of sonication, the cell lysate was homogenised using a 
tissue grinder and incubated for two to four hours at 4°C whilst being gently mixed. 
Furthermore, post incubation the cell lysate underwent ultracentrifugation using 
a BeckmannTM LE-80K with a T70ti rota at 45,000rpm for 1 hour (4°C). The 
ultracentrifuged cell lysate was then removed from the centrifuge and the 
supernatant was immediately extracted on ice. In addition, the pelleted cellular 
membranes were resuspended in extraction buffer and flash frozen in liquid 
nitrogen for later analysis if necessary. As this protocol is using detergent for 
solubilisation it was not deemed as necessary to perform a dialysis procedure of 
the extracted supernatant. Therefore, it was possible to continue forward onto 
our primary purification phase of IMAC. This purification procedure was followed 
in the same accordance as described previously, however both the equilibration 
buffer and elution buffer differed. As we were using detergent for our 
solubilisation protocol it was crucial that all purification systems must be 
equilibrated with detergent also to ensure stability and prevent protein 
precipitation out of solution.  Due to pressure constraints and affinity interactions 
of HisTrapTM nickel columns it was vital that both the LMNG and CHS buffer 
concentration decreased 10-fold during this procedure. For our detergent IMAC 
purification 0.1% LMNG (w/v) and 0.01& CHS (w/v) was supplemented to our 
previously prepared HEPES-buffered saline. In addition, it was crucial that both 
the LMNG and CHS had completely dissolved into the buffer as this could have 
compromised the entire procedure.  
 
Bradley Hilton 
 pg. 45 
Following completion of the IMAC procedure with the addition of LMNG and CHS, 
4mL buffer B elutions were immediately collected and transferred for storage at 
4°C. Using the same protocol for SEC, used for C43 expressed sigma-1, both the 
equilibration buffer and elution buffer were prepared to similar standards. The 
only varying factor was that these buffers were supplemented with a decreased 
concentration of LMNG (0.01% w/v) and CHS (0.001% w/v) to maintain a stable 
pressure throughout the procedure. Upon completion of this secondary 
purification protocol 0.5mL fractions were immediately stored at 4°C whilst data 
was analysed for the select screening of the peak elutions using SDS-PAGE. Once 
likely candidates were selected, samples were then spin concentrated using a 
10KDa spin column at 4,000rpm for 30minutes using a Beckmann table-top 
centrifuge.  
 
Furthermore, upon extraction of the concentrated sample a TEV cleavage 
procedure was set up immediately at 4°C. Due to the expense of LMNG and CHS 
reagents it was decided that the TEV cleavage procedure would be performed by 
directly incubating the protease with the sigma-1 sample at pH 7.5. Although 
these are not the ideal conditions for a TEV cleavage procedure it was deemed as 
necessary to ensure the stability of sigma-1 and to reduce the overuse of LMNG 
and CHS. After 12 to 16 hours of TEV protease incubation the sigma-1 detergent 
solubilised sample was immediately placed on ice for a second IMAC procedure. 
Using the same protocol previously used for TEV cleaved sigma-1 nanodiscs, all 
systems and procedures were set up to the same the standards. As our desired 
protein was still solubilised with detergent it was deemed as necessary to 
maintain stability of our protein by maintaining the buffer concentration of LMNG 
at 0.01% (w/v) and CHS at 0.001% (w/v). Following the procedure all wash, flow 
through and elution samples were stored at 4°C in preparation for SDS-PAGE, in-
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2.10 In-gel fluorescence (IGF) For Green Fluorescent Protein Sample Screening 
 
As an additional screening method for our samples post purification and prior to 
performing a TEV-cleavage method it was deemed as beneficial to assess whether 
the protein identified on previous SDS-PAGE gels were in fact free GFP or bound 
GFP to sigma-1. In order to do so we prepared a unique sample buffer that has 
been utilised in many studies for the purpose of GFP screening. This buffer also 
known as IGF-SB (In-gel fluorescence sample buffer) consisted of the following 
reagents; 50mM Tris-HCl (pH 7.6), 5% glycerol (v/v), 5mM EDTA (pH 8.0) and 
0.02% bromophenol blue in stocks of 700μl (stored at -20°C). Prior to using the IGF-
SB it was necessary to supplement the stocks with 200μl of 20% SDS (w/v) and 
100μl 0.5M DTT. These freshly prepared stocks could be stored at room 
temperature up to 20 to 30 days or for long term storage at -20°C. Using the IGF-
SB, samples were prepared following the same protocol for SDS-PAGE. 
Furthermore, 20μl of concentrated samples were supplemented with 10μl of IGF-
SB at room temperature and were not heated as this could degrade GFP 
fluorescence. Following this, all necessary samples were loaded onto a gel along 
with 5μl of Precision Plus Protein Dual Colour Ladder and run at 200V for 30 to 45 
minutes. Post SDS-PAGE running, the gel was immediately transferred to a 
SynGeneTM (CHEMI-XRQ) CCD camera for blue light (EPI source) ultraviolet imaging 
at 460nm and 515nm cut-off 
 
2.11 Western Blotting for Isolated Sigma-1 Post TEV Cleavage Protocol 
Once we had screened our TEV cleaved elutions post IMAC it was then deemed 
necessary to confirm whether these were isolated sigma-1 samples. This protocol 
can be divided into five distinct phases, which include; protein electrophoresis, 
membrane transfer, membrane blocking, antibody incubation and detection. In 
order to carry out this screening procedures it was necessary to prepare the 
following buffers; transfer buffer, blocking buffer, Tris-buffered saline (TBS), and 
Tris-buffered saline-tween (TBST). The primary step of this protocol is to loaded 
samples following the same method for SDS-PAGE. During this stage proteins will 
separate according to their molecular weight and do not require post staining for 
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this procedure. For this protocol 5μl Precision Plus ProteinTM Dual Colour pre-
stained ladder was used to ensure easy confirmation of successful membrane 
transfer. Upon running the gel at 200V for 45 minutes, the gel was prepared for 
polyvinylidene difluoride (PVDF: Bio-Rad Immune-BlotTM) membrane transfer 
using a semi-dry method. In order to carry out this transfer procedure the PVDF 






In addition, filter paper stacks (Bio-Rad: Absorbent filter paper) were then 
equilibrated in 1x Tris-buffered saline. Once both the PVDF membrane and filter 
stacks had been treated, it was then possible to prepare the cassette for blotting 
membrane transfer. The transfer cassette was prepared in the following order to 
ensure that the current was travelling in the correct direction; negatively charged 
cathode, top filter paper stack, SDS-PAGE gel, blotting membrane, bottom filter 
paper stack and positively charge anode. Once the final transfer stack had been 
successfully prepared it was then transferred into Trans-Blot Turbo Transfer 
system. Upon insertion to the device, the transfer procedure was run for 7 
minutes at 20V until complete transfer was achieved. Once the transfer procedure 
was complete, the PVDF membrane was checked to ensure that the SDS-PAGE gel 
had been successfully transferred. If the transfer was confirmed, the membrane 
was then blocked using 10mL of blocking buffer. This buffer consisted of 5% 
skimmed milk powder (w/v) in 1x Tris-buffered saline-tween. This blocking 
procedure took place at room temperature using a digital benchtop shaker at 
Ve – Cathode Cassette Top  
Ve + Anode Cassette Bottom 
Figure 11: Diagram showing how western blot was prepared for SDS-
PAGE gel transfer to PVDF membrane. Western Blot Transfer Setup. 
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80rpm for 1 hour. Whilst this blocking procedure was taking place, it was 
necessary to prepare the primary antibody over ice as thawing was timely. For our 
primary antibody incubation, we ordered the Sigma-1 Receptor Polyclonal 
Antibody (product no: 42-3300) from ThermoFisherTM due to its high specificity for 
the sigma-1. This unconjugated IgG antibody was derived from rabbit and 
required incubation with a secondary anti-rabbit IgG antibody for this blotting 
procedure. In order to prepare the correct working concentration of this antibody 
(1:1000) a dilution in blocking buffer was used to maintain a final incubation 
concentration of 2μg/mL.   
 
Once the primary antibody was successfully prepared and the membrane blocking 
phase was complete, it was the necessary to pour off the blocking buffer from the 
membrane. Upon removal of the blocking buffer, the membrane was then 
supplemented with 10mL of primary antibody in blocking buffer and left to 
incubate at room temperature for 1 hour. Once primary antibody incubation was 
complete, the membrane was then washed using freshly prepared TBST in 5 
individual wash cycles for 5 minutes per cycle. Following this, it was then 
necessary to prepare the secondary antibody in blocking buffer over ice. For our 
secondary antibody, we used the Goat Anti-rabbit IgG HRP-Linked Antibody 
(product no:65-6120) supplied from ThermoFisher. This secondary antibody 
(stock concentration 1mg/mL) was 1/10,000 diluted into blocking buffer and 
applied to the blotting membrane for 1 hour at room temperature on a digital 
benchtop shaker at 80rpm.Once the blotting membrane had been incubated for 
the specified time, it was then necessary to wash the blotting membrane again 
using 4 TBST wash cycles for 5 minutes and 2 TBS wash cycles at 5 minutes per 
cycle. Upon completion of the wash cycle it was then necessary to prepare the 
membrane for imaging using enhanced chemiluminescence reagent (ECL). As our 
secondary rabbit IgG antibody was linked to the enzyme horseradish peroxide 
(HRP) it was possible to detect its activity using photographic imaging. For this 
procedure we used PeirceTM ECL western blot substrate reagent (product no. 
32106) due to its compatibility with PDVF blotting membranes.  
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Once the membrane had been sufficiently washed using both TBST and TBS, 1mL 
of the ECL reagent was directly applied for imaging. The ECL reagent was prepared 
in a 1:1 ratio, by mixing peroxide solution with luminol solution in a clean 
Eppendorf and then wrapped in aluminium foil to ensure chemical stability. The 
light emission peak for ECL reagent ranges between 5 to 20 minutes so it was 
crucial that we applied this at the moment of imaging. Once the membrane was 
exposed to the ECL for 3 minutes in a CCD camera, the blot was imaged at a 
maximum wavelength of 425nm using a preinstalled method for this procedure. 
It is considered that most suitable conditions for membrane blocking and antibody 
incubation, is at 4°C overnight. Typically, when western blotting is performed to 
this standard there is a stronger detection signal with specificity and sensitivity. 
Unfortunately, we only blocked our PDVF membrane and incubated our 
antibodies for 1 hour at room temperature. This may have had an impact on the 



















2.12 INVSc1 as an Expression System for Sigma-1 
In order to create a suitable construct for the transformation of INVSc1 competent 
cells, a multistep protocol was implemented. This included the following; primer 
design, fragment/vector PCR, product screening, restriction & ligation, 
Figure 12: Flow diagram representing key aspects of the western blot protocol implemented 
for determining sigma-1 isolation in both INVSc1 and C43 expression systems. Overview of 
the Implemented Western Blot Protocol. 
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transformation and sequence screening. The plasmid of choice for the insertion 
of our sigma-1 fragment was the LEU2 pop in vector, which has been introduced 
into both C43 and INVSc1 strains for protein expression in many publications. In 
order to create this final construct, it was first important to amplify both the 
sigma-1 fragment and LEU2 plasmid using specifically designed primers in two 
PCR’s. In principle these reactions would result in both the fragment and vector 
possessing complementary amino acid overhangs by which they can be 
incorporated together via pfu polymerase ligation. Using our previously 
constructed sigma-1 modified pCold-1 vector used for C43 expression it was 
possible to amplify our protein sequence from this template using two designed 


















In addition to the amplification of the fragment DNA it was also necessary to 
amplify our vector with its fragment complementary overhangs. These primers 
were designed to be complementary either upstream and downstream of a SMaI 
restriction site so that both the fragment and vector can be easily incorporated 
into a linearized construct. In order to carry out this procedure a standard PCR 
protocol was followed, however specific phases of the reaction were altered by 
temperature and time.  
 
Figure: 13: Imagine taken of the final S1R-LEU2 construct used for the transformation of 
saccharomyces cerevisiae for sigma-1 expression. Final Sigma-1 LEU2 Construct for 
INVSc Transformation. 
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2.13 Sample Preparation for Polymerase Chain Reaction (PCR) 
For both amplification procedures three reactants were prepared using pfu 
polymerase to catalyse the reaction. In principle sample 1 and 2 were designed to 
be our stocks of product whereas sample 3 would be a control without the 
addition of pfu polymerase. This would enable us to compare sample 3 to the 
product samples by DNA testing methods such as nanodropTM and DNA 
electrophoresis. Once the final volumes of each reagent were supplemented to 
each sample on ice, they were then transferred to the PCR running device. In order 
to perform a PCR protocol, it was necessary to determine the overhang tm’s of 
both the vector and the fragment primers. This is a crucial step as the annealing 
phase of PCR is temperature sensitive and may have resulted in unbinding of 
primers to complementary nucleotides. 
 
Table: (2) Sigma-1 Fragment Primers for Annealing Tm’s in LEU2 Construct. 
 
Table: (3) LEU2 Designed Plasmid Primer Annealing Tm’s. 
  




Sequence Tm complete 
primer 












Sequence Tm complete 
primer 
Tm part Annealing Tm 




Reagent Sample 1 Sample 2 Sample 3 (Control) 
10 x buffer pfu 
polymerase  
5ul 5ul 5ul 
DNTP’s 1ul 1ul 1ul 
Upstream primer 0.5ul 0.5ul 0.5ul 
Reverse primer 0.5ul 0.5ul 0.5ul 
Vector or Fragment 
Sample 
1ul 1ul    1ul (1/10) 
Polymerase 1ul 1ul 0 
Milli-Q water 41ul 41ul 42 
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Both the sigma-1 fragment and LEU2 vector primers were ordered via Eurofins 
Scientific and upon obtainment they were stored at -20°C until required for use. 
Furthermore, once the appropriate melting temperatures of the primers were 
determined it was then possible to prepare all three reactants including a single 
control sample. Two of these reactants were to be our stocks of the amplified 
vector or fragment and the third would be a control sample not containing the 
enzyme pfu polymerase from Promega Express (product no.M7741) with a 10-fold 
dilution of DNA in Milli-Q water. Following sample preparation over ice, they were 
then transferred to the PCR reactor system and all parameters were set 
accordingly. For a standard PCR reaction there are distinct phases; 1) initial 
denaturation, 2) denaturation, 3) annealing, 4) extension and 5) final extension.  
The PCR set-up for the plasmid differed to the fragment during at the final 
extension phase due to the total base pair the size of the vector at 8689bp. 
Because of this, after optimisation we used 2min/kilobase (kb) for the final 
extension when amplifying our plasmid and fragment with pfu DNA polymerase. 
Although our sigma-1 fragment size was a total of 669bp, we decided after 
optimisation to increase the final extension time to a total of 5 minutes to ensure 
correct amplification. 
 
Table (5): Polymerase Chain Reaction (PCR) Modifiable Protocol for Fragment 
DNA And Plasmid DNA 
Step Temperature  Time Number of Cycles 
Initial Denaturation  95°C 1 minute 1 Cycle  
Denaturation  95 °C 45 seconds 1 Cycle 
Annealing 55 °C 30 seconds  30 cycles 
Extension  72 °C 2 - 4 minutes 1 Cycle 
Final Extension  72 °C 5 minutes (Fragment) / 10 
minutes (Plasmid) 
1 Cycles 
Soak (Finish) 4°C Indefinite  1 Cycles  
 
 
After a complete run of the PCR procedure both the plasmid and fragment double 
stranded DNA samples were measured using a nanodropTM dual device. Using 2ul 
per sample, all three reactants including the control dsDNA concentrations were 
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measured at 260nm. For this particular PCR we measured the average fragment 
concentration at 121.2ng/μl, average plasmid concentration at 94.2ng/μl and the 
average control sample at 16ng/μl. As the control samples concentration was 
much less than that of the DNA stock samples it was considered that the PCR 
procedure had been a success. These samples after analysis were then stored at 
4°C until the transformation procedure commenced. Before the transformation 
procedure took place, it was crucial that the saccharomyces cerevisiae cells were 
treated to develop competency. For this particular protocol it was deemed as 
efficient to produce chemical competent cells with the addition of lithium acetate 
(LiAc). This protocol was influenced by a publication in 2008 by Newstead et al 
called “GFP-based optimisation scheme for the overexpression and purification of 
eukaryotic membrane proteins in…”. Although the protocol we used for protein in 
expression in our yeast cells is very similar to Newstead et al, there are instances 
of modified procedure’s which were deemed necessary for our desired protein. 
 
2.14 Preparation for Yeast Cell Competency  
Prior to the cell competency procedure, a Yeast Peptone Dextrose (YPD) agar plate 
was inoculated using a sterile loop and incubated overnight at 30°C to create 
multiple colonies. After 12 to 16 hours of incubation the plate was removed from 
the incubator and placed on a sterile bench, ready for the next procedure. Under 
aseptic conditions a sterile loop was used to inoculate YPD medium with the 
INSVc1 plated cells into a 50mL falcon tube. The starter culture was then 
transferred into an orbital shaker set to 30°C at 280 rpm for overnight incubation. 
Following this, the culture was then diluted into 50mL of YPD for an OD600 of 0.1 
prior to incubation. After assessing the culture, it was then incubated at 30°C in an 
orbital shaker, set to 280rpm until an OD600 of 0.5 was achieved. The culture was 
then centrifuged at 13,000g for 10 minutes using a BeckmannTM tabletop 
centrifuge at 4°C. The supernatant was discarded, and the pelleted cells were 
resuspended in ddH2O over ice. Following this the resuspended cells were then 
further centrifuged at 13,000 for 5 minutes using the same centrifuge at 4°C. The 
supernatant was also discarded; however, the cellular pellet was resuspended in 
100mM LiAc over ice. Furthermore, the resuspended cells were further 
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centrifuged at 13,000g for 30 seconds before the supernatant was discarded and 
the pellet was resuspended in 500μl of 100 mM LiAc. This cellular competency 
protocol took a total two days to complete, so it was important that all reagents 
were prepared prior to performing the next transformation procedure. 
 
In order to prepare the required medium and drop out plates for a selective 
INSVc1 culture growth, we used a multistep process to do so. In order to prepare 
the selective  drop out medium for -uracil (-URA)  and -leucine (-LEU)  plates, we 
used the following reagents; synthetic yeast base without amino acids, dextrose,  
Bacto-agar and either the -uracil or -leucine drop out medium, which contained 
all the necessary amino acids for normal yeast cellular growth except those two 
amino acids. In addition to the preparation of selectivity plates it was also 
necessary to prepare, the growth medium for the INSVc1 cells post colony 
selection for the starter culture and larger scale growth. In order to do so we used 
the same protocol for preparing the selectivity plates, however without the 
addition of Bacto-agar in the media.  
 
2.15 Transformation Protocol for INSVc1 Expression System 
The transformation procedure was more complex and required a high level of 
time management to perform correctly in comparison to our previous heat shock 
system in C43 expression. Prior to performing this protocol, it was necessary to 
ensure that the LEU2 plasmid had been digested by the SMaI restriction enzyme 
to allow insertion of the sigma-1 fragment DNA into the specific site. For this 
protocol we used the FastDigest SMaI restriction enzyme that recognises the 
5’CCC-GGG3’ sequence and digests with a high level of activity. In addition, this 
protocol did not require post buffer exchange or further DNA clean up steps and 
deactivation of the enzyme was possible in a fast procedure. In order to perform 
this procedure, the following reaction components were added to a 1.5mL 
Eppendorf tube; Milli-Q water, 1X FastDigest buffer, our plasmid DNA (102ng/μl) 
and the FastDigest restriction enzyme (total volume of 20μl per reaction). Post 
preparation, the reactant was gently mixed at room temperature before being 
incubated in a water thermostat set to 37°C for 5 minutes. After the reaction had 
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taken place, the SMaI was inactivated at 65°C for a further 5 minutes in a different 
water thermostat. Post to the inactivation protocol the reactant was then stored 
at 4°C until required for the transformation procedure.  
 
To start the transformation procedure 50% (w/v) PEG 3350 was supplemented to 
a clean 1.5mL Eppendorf tube on ice. The previously prepared competent INSVc1 
cells were also placed on ice and were then transferred to the 50% PEG 3350. The 
transformant was vortexed for 5s to ensure complete mixture and then placed 
back on ice. Following this the mixture was then supplemented with 2mg ml-1 
salmon sperm (single-stranded carrier DNA) and was then further vortexed for 5 
seconds. This transformant was then ready to be supplemented with the addition 
of a DNA mixture consisting of both SMaI LEU2 digested plasmid and the sigma-1 
PCR fragment. Firstly, Milli-Q water was dispensed into a clean Eppendorf with 
the addition of 3μl of the digested plasmid (minimum 25ng/μl-1) and 5μl of the 
sigma-1 PCR fragment (minimum 150ng/μl-1). This 50μl DNA mixture was then 
added to the transformant and vortexed for a further 5 seconds. The transformant 
mixture was then immediately transferred to an orbital shaking incubator set to 
30°C at 180rpm for 30 minutes. Post Incubation the transformant underwent a 
heat shock phase in a water thermostat set to 42°C for 25 minutes. Once the heat 
shock procedure was complete it was then possible to prepare for plating the 
transformant on a -URA selective agar plate. Furthermore, the heat shocked 
transformant was then centrifuged at 8,000g for 15 seconds at room temperature. 
The supernatant was discarded, and the cellular pellet was resuspended in sterile 
Milli-Q water. This cellular suspension was then plated onto a -URA agar plate 
under aseptic conditions and left to incubate at 30°C for 2-3 days. Once the -URA 
selectivity plate had been incubated for the required time, it was then necessary 
to screen for isolated colonies for further selection. Once isolated colonies had 
been confirmed a single colony was used to streak a -LEU selectivity plate to aid 
in the double selection process. This plate was also incubated at 30°C for 2 to 3 
days until there were visible colonies present. After -LEU plate incubation it was 
then stored at 4°C until preparations for growth were achieved 
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2.16 Sigma-1 Growth Protocol in Transformed INSVc1 Cells   
The previously cultured -LEU plate with isolated colonies was used to inoculate 
the -URA medium supplemented with 2% dextrose (w/v) in a 50mL falcon tube. 
As yeasts metabolic pathway involves fermentation it was crucial to ensure that 
the falcon tube cap was loosely sealed to reduce culture toxicity. This starter 
culture was then transferred to an orbital shaking incubator set to 30°C at 280rpm 
for overnight incubation. After 12 to 16 hours of growth, the culture was further 
diluted to an OD600 of 0.1 using 10mL of -URA medium supplemented with 0.1% 
dextrose (w/v). At this stage it was important to decrease glucose concentrations 
in the growth medium as higher concentrations can supress the GAL1 promoter 
used for induction. Following the dilution stage, the cultures were then 
transferred to an orbital shaking incubator set to 30°C at 280rpm until an OD600 of 
0.6 was achieved. Typically, achieving this OD600 level would take around 6 to 8 
hours as the approximate doubling time for yeast cells is 90 to 120 minutes. Once 
this OD600 level was reached it was then curial to perform an induction procedure 
with the addition of galactose. For our induction protocol we prepared a 20% 
galactose (w/v) stock in -URA medium so that the final culture concentration 
would equate to 2%. After approximately 22 hours post induction, these cultures 
were centrifuged at 4,000rpm for 20 minutes using a BeckmannTM tabletop 
centrifuge. Typically for this procedure we would size up this protocol to gain 
500mL of INSVc1 culture per growth in 25 individual 50mL sterile falcon tubes. 
This would enable us extract and screen for our desired protein even if its 
overexpression levels are minimum.  Post centrifugation, the supernatants of all 
the cultures were discarded and the INSVc1 cellular pellet was resuspended in the 
appropriate lysis buffer. Just as in the C43 expression system protocol, the 
procedure for solubilisation alternated depending upon whether it was a 
detergent based method or a native extraction using nanodiscs. When extracting 
sigma-1 GFP tagged complexes with detergent, all pellets were resuspended using 
30 to 60mL of 1% LMNG (w/v), 0.1 CHS (w/v) in 1x HEPES-buffered saline. 
 
Just as in the for the C43 expression, this cell lysate would then be supplemented 
with the appropriate volume of HaltTM protease inhibitor 100X (EDTA free) single-
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use cocktail and proceed to sonication. In contract, if the sigma-1 GFP tagged 
complexes were to be extracted using SMI or SMA nanodisc then the sonicated 
cell lysate in 1x HEPES-buffered saline, would be supplemented to a final 
concentration of 2% (w/v) with a pre-prepared nanodiscs reagent.  Furthermore, 
these nanodisc samples would also undergo a dialysis procedure to remove any 
free unbound nanodiscs. Post extraction the sigma-1 solubilised samples would 
undergo a primary (IMAC) and secondary (SEC) purification methods along with 
any necessary screening procedures such as SDS-PAGE, In-gel fluorescence and 
GFP fluorescence measurements via a plate reader. Once samples had been 
selected through screening methods as viable then they would undergo a TEV-
cleavage procedure to isolate sigma-1 from its counterpart GFP tag.  Furthermore, 
following procedure the sample would undergo a western blot to confirm that we 
have isolated our desired protein. 
 
2.17 Transmission Electron Microscopy (TEM) Screening Methodology 
 
Following purification of the sigma-1 2% SMA Imide 1:1 complex using size-
exclusion chromatography, it was deemed appropriate to screen these samples 
for presence of these nanodisc complexes. An effective method for this 
assessment is the use of electron microscopy, which has the ability to visualize 
particles at a resolution of 0.2 nm (up to 500,000x magnification). After observing 
UV detector peaks (AU 280nm) generated on the SEC run of the C43 sigma-1 SMA 
imide (1:1) samples we carried out a negative stain TEM on five fractions that we 
suspected to be the most likely to contain sigma-1 GFP tagged nanodisc 
complexes. For this procedure copper grids were set up for negative staining using 
the carbon floating method. Samples to be tested through this method were not 
further diluted as we wanted to identify a high concentration of nanodiscs 
throughout the image. Firstly, samples were dispensed onto carbon-coated mica 
so that they could be sufficiently absorbed for imaging. Once absorbed, the 
carbon-coated mica was transferred to be stained with a single drop of 2% uranyl 
acetate to cause detachment from the carbon grid. Furthermore, a secondary 
copper grid was placed on top the unmounted carbon grid and the negative 
stained carbon grids were left to dry before imaging. Once dried, the negative 
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stained carbon grids were loaded into a FEI Tecnai T12 transmission electron 
microscope and imaged at 30,000x magnification22. The imaging procedure 
consisted of scanning across the scanning across the carbon coated grid at a 
resolution of 20 to 100nm for identification of these nanodisc formations. During 
the analysis of the samples it was conclude that there may have also been 
potential contaminants within these samples due to the identification of many 
unexpected artefacts within the samples. Furthermore, this method proved as 
highly beneficial for the detection of nanodisc formations within our samples. 
 
2.18 Nuclear Magnetic Resonance (NMR) Sample Preparation  
 
For our NMR studies we prepared samples to a total volume of 550µl with varying 
experimental factors. All samples were prepared with varying volumes of sample 
buffer and ddH20 to achieve the required total volume of 550µl. The NMR 
experiments included the following samples to be tested on different spectra;  
 
• Testing sample 1: 50µM isolated sigma-1 (without drug), sample buffer; 
1x HEPES-buffered saline supplemented with 0.1% LMNG and 0.01% CHS 
and ddH20 (Total volume of 550µl 
 
• Testing sample 2: 50µM isolated sigma-1, 15.5mM fluoxetine 
hydrochloride, sample buffer; 1x HEPES-buffered saline supplemented 
with 0.2% LMNG and 0.01% CHS and ddH20 (Total volume of 550µl) 
 
• Drug with detergent sample (no Sigma-1): 15mM fluoxetine 
hydrochloride and sample buffer; 1x HEPES-buffered saline supplemented 
with 0.2% LMNG and 0.01% CHS and ddH20 (Total volume of 550µl) 
 
• Drug without detergent sample (no sigma-1): 15mM fluoxetine 
hydrochloride and sample buffer; 1x HEPES-buffered saline (Total volume 
of 550µl) 
Once the 550µl samples had been prepared accordingly, they were then 
dispensed into a green top 7” NMR sample tube carefully to avoid bubble 
formation. The prepared samples were then individually inserted into a 600 MHz 
five channel Bruker Avance III spectrometer and the specific experimental system 
protocol was loaded onto the automated console.  
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Construct Design: C43 and     





Sigma-1 Receptor Extraction Via 
Detergent based or Copolymer 
Resins I.e. SMAs 
 
Primary Screening via 
SDS-PAGE / GFP 
Fluorescence 
Isolated Sigma-1 GFP complex 
primary & secondary purification 
i.e. IMAC / TEV Protease 
Cleavage 
 
Secondary Screening via 
SDS-PAGE / GFP 
Fluorescence 
Sigma-1 Receptor 
Characterisation & NMR 







Vector & Fragment PCR 
Restriction Site Digestion & 
Ligation 
 
Figure 14: Flow Diagram of basic project phases from construct design to sigma-1 receptor characterisation. 
Complete Research Project Overview. 
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3: Results and Discussion  
 
C43 Expression System Results & Discussion 
 





Prior to inducing our C43 cells with 1mM/L IPTG it was necessary to measure the 
OD600 in order to estimate the cellular concentration in the TB medium. 
Furthermore, at this stage it was crucial that we reach an OD600 that surpassed lag 
phase of growth and was in exponential growth phase in order to maximise 
cellular density and viability. The data for figure 15, is comprised of the average 
OD600 measurements of 4L C43 TB growth flasks and the data clearly demonstrates 



























OD600 Of 1L C43 Cell Growth Prior To 1mM/L IPTG Induction 
Figure 15: Average Optical Density (OD600) Data of Sigma-1 C43 Cellular Growth in 1L 
Terrific Broth Medium Prior Induction. C43 Cell Growth Graph prior to IPTG Induction. 
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Using the principle that an OD600 of 1.0 is equal to 8 x 108 cells/mL it was possible 
to calculate each specific OD600 corresponding cellular density. Furthermore, it is 
clear to see in the early stages of growth between timepoint 0 minutes to 120 
minutes the cells appear to almost double then the rate of exponential growth 
decreases at 120 minutes to 180 minutes. This could indicate that these cells were 
in fact entering stationary phase, meaning that all available growth medium 
nutrients began to become depleted for further growth. At 180 minutes we 
achieved an OD600 of 1.12 which equates to a cellular density of 8.96 x 108. Ideally, 
it may have been beneficial and more suitable to induce these cells at a lower 
OD600 as the cell viability may have decreased with increase in cell density. This 
could have potentially had an impact on our recombinant protein expression in 
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The IMAC AKTA start purification system was deployed as part of our primary 
purification system for all our expression vectors. In addition, the procedure for 
running this method remained the same throughout all solubilisation techniques 
whether that be via nanodiscs or detergent based methods. This procedure was 
divided into 6 distinct phases; 1) primary column wash, 2) column equilibration, 
3) sample run, 4) secondary column wash, 5) elution phase, and 6) sample 
collection. During all IMAC phases, the key tool for analysis was that of an 
ultraviolet (UV) detector set to a wavelength of 280nm. Following the sample run 
procedure, both the UV and conductivity levels sharply increased as a high 
concentration of proteins passed through the system to the flow through 
collector.  
Figure 16: demonstrates graphical representation of the IMAC purification performed on SMI 
solubilised sigma-1 tagged GFP complexes. At 35% to 100% buffer B concentration we see a 
sharp increase in UV (AU 280nm) detection followed by an increase in conductivity. Fractions in 
tubes 6-17 were later screened by SDS-PAGE to determine the likelihood of sigma-1 GFP tagged 
complexes isolation. Graph Showing IMAC Run on Solubilised Sigma-1 using SMA Imide 1000I. 
-Concentration Gradient          -UV Absorbance (AU 280nm)        -Conductivity 
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Once the sample had entirely been passed through the system, and the secondary 
wash procedure had commenced we saw a steady decrease in the UV (280nm) 
reading along with conductivity. This was an indication that all unspecific bound 
proteins had been removed from the system and it was possible to elute our 
desired protein which should theoretically bound to the 5mL His-TrapTM affinity 
nickel column. Using a concentration of 500mM imidazole (0% to 100%) any 
bound proteins to the nickel column were eluted over 17 fractions of 4mL. In 
figure 16, at 40%-45% imidazole concentration and 24mL to 32mL we see the two 
peak UV elution of protein in fraction 7 and 8 (T7 & T8). After these peak elutions 
there is a steady decrease in UV detection until T17 indicating our desired protein 
may be eluted in high concentration in both fractions 7 & fraction 8, with 
decreasing concentration in all elutions up to fraction 17.  
 
Although these results provide a strong indication for the presence of sigma-1 GFP 
tagged nanodisc complexes there are a few factors to take into consideration. 
Imidazole also has an ultraviolet absorbance at 280nm which could equate to an 
increase in total UV absorbance throughout the procedure. In addition, the exact 
concentration gradient readings may be inaccurate to difficulties in equilibrating 
both pump A and pump B before the elution phase. In order to assess these 
fractions for our desired protein it was then necessary to screen via SDS-PAGE to 
ensure eluted proteins were of expected molecular weight. As we solubilised our 
membrane protein using both nanodiscs and detergents in separate procedures 
we also obtained AKTA start purification graphs for SMA 2:1 and LMNG. The 
results of these graphs followed a similar pattern when comparing that to the SMA 
imide sigma-1 procedure as we detected UV 280nm peak elutions between 40% 
to 60% imidazole concentration. Unfortunately, due to technical errors in the 
AKTA purification procedures we were not able to obtain graphs for the IMAC 
purification of the SMA 2:1 or the 0.1% LMNG sigma-1 samples. However, all 
analysis at the time of purification matched the same trends as seen in the AKTA 
purification of SMA imide 1:1 sigma-1 samples. 
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After obtaining elutions for the SMA Imide 1:1 AKTA start purification all elutions 
were run on an SDS-PAGE to screen for sigma-1 GFP tagged SMA imide nanodisc 
complexes. In figure 17, elutions T1 to T4 were spin concentrated using a 10KDa 
spin column however we still see no indication for the presence of proteins in 
these samples. It is only until we analyse elutions T7 to T17 we can see a significant 
concentration of various proteins in the SDS-PAGE. In samples T7 to T9 we see 
distinct bands at around 50KDa which proved to be a promising indication for the 
isolation of sigma-1 GFP tagged SMA imide nanodisc complexes. Furthermore, 
elutions T7 to T17 we also see distinct bands at around 70KDa which was not to 
be expected. However, a rational explanation for this could be the fact that 
previous publications on the analysis of nanodiscs have demonstrated varying disc 
Figure 17: Image taken of SDS-PAGE gel screening for C43 expressed sigma-
1-GFP tagged SMA imide nanodisc complexes. Lane 1 contains PageRulerTM 
protein ladder (5 to 250KDa) and lanes 2 to 15 contain elution samples from 
previous IMAC purification procedure. Lane 1 contains a spin concentrated 
sample obtained from elutions 1 to 4 using a centrifuge at 4,000rpm for 30 
minutes. In addition, circled is the potential sigma-1 GFP tagged SMI nanodisc 
complexes. SDS-PAGE Result Post IMAC Run of Solubilised Sigma-1 
Complexes using SMA Imide 1000I. 
Figure 18: 5-250 
kDa PageRulerTM 
protein ladder 23. 
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formations at increasing molecular weights. In addition, as nanodiscs have the 
solubilise disc formations of native membranes it is possible that the size of these 
lipids surrounding our protein also vary in size and molecular weight. 
Furthermore, once we had an indication for the presence of sigma-1 nanodisc 
complexes these samples were spin concentrated for secondary purification using 
size-exclusion chromatography (SEC).  









In addition to the SMA imide 1:1 SDS-PAGE screening it was also necessary to 
screen the SMA 2:1 elutions post AKTA start purification. The results of this SDS-
PAGE surprised us we did not anticipate such abnormal results when running the 
SMA 2:1 elutions upon an SDS gel. As we can see, figure 19 shows that all elution 
samples failed to pass through to the separating section of the gel and appear to 
be majorly aggregated. After multiple attempts to run a successful gel using SMA 
2:1 nanodiscs it was deemed unsuccessful and we decided to abandon this 
method of solubilisation. This gel shows a strong indication that the SDS in the gel 
did not denature the nanodiscs to produce a net negative charge of the overall 
Figure 20: 5-250 
kDa PageRulerTM 
protein ladder 23. 
Page Ruler Protein 
Ladder Reference 
 
Figure 19: Image taken of SDS-PAGE gel screening for C43 expressed 
sigma-1 GFP tagged SMA 2:1 nanodisc complexes. Lane 1 contains 
PageRulerTM protein ladder (5 to 250KDa). lane 2 to lane 10 contained 
elutions T6 to T14, lane 11 contains flow through sample and lane 12 
contains wash sample. SDS-PAGE Result Post IMAC Run of Solubilised 
Sigma-1 Complexes using SMA 2000I. 
LAD    TL6    TL7   TL8    TL9    TL10  T11   T12   T13    T14    FT   WH 
LAD    TL6    TL7   TL8    TL9    TL10  T11   T12   T13    T14    FT   WH 
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complexes or the SMA nanodiscs resin solubilisation procedure was not 
performed correctly resulting in an abnormal chemical property. In addition, for 
the SDS-PAGE procedure we speculated that the acrylamide concentration of 10% 
was too high and prepared gels at 8% in order to increase gel pore size for heaver 
molecular weight complexes. This attempt also failed, leading us to stop using 
SMA 2:1 for the solubilisation of our protein and focus on using SMA imide 1:1 

























After analysing figure 21, it is clear to see that there many proteins present at 
varying molecular weights. Overall, we do not see any bands with particular 
intensity at any other molecular weights apart from at 100KDa in both elution 
samples T7 and T8. However, we still do see bands at around 50KDa which still 
provides some indication of our desired protein being expressed in this system. 
Ideally, we would have expected these bands at 50KDa to be have much more 
intensity than any other protein band present on this gel. Furthermore, as the 
Figure 21: Image taken of SDS-PAGE gel screening for C43 expressed 
sigma-1 GFP tagged 0.1% LMNG & 0.01% CHS elutions. Lane 1 contains 
PageRulerTM protein ladder (5 to 250KDa), lane 2 to lane 10 contains 
elutions T5 to T13, lane 11 contains FT sample, and lane 12 is the wash 
sample. SDS-PAGE Result Post IMAC Run of Solubilised Sigma-1 
Complexes using LMNG and CHS. 
        LAD    T5    T6    T7      T8    T9   T10   T11   T12   T13 FT  WH 
Figure 22: 5-250 
kDa PageRulerTM 
protein ladder 23. 
Page Ruler Protein 
Ladder Reference 
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results of this gel correlates with the SMA imide 1:1 sample elutions, this must be 
deemed as a significant finding and as these protein bands could potentially be 
the solubilised sigma-1 receptor. 
 










Once there was an indication post AKTA start purification for the presence of 
sigma-1 GFP tagged complexes, 250μl of elutions T1 to T11 were assessed for GFP 
fluorescence using a 96 well microplate.  As we can see, elutions 1 to 7 contain 
relatively low levels of GFP fluorescence, however as we get to elution 8 it is clear 
to see a sharp increase in the RFU of this sample. In the contrary, we begin to see 
a decrease from elutions 9 to 11 which indicated that elution 8 contained the 
highest concentration of sigma-1 GFP tagged SMA imide nanodiscs. Although, we 
see a significant RFU level of GFP in elution 8, this does not necessarily directly 

















AKTA START PURIFICATION ELUTIONS
RFU Levels of Sigma-1 GFP Tagged SMA Imide 1:1 
Nanodisc Complexes 
Figure 23: Shows GFP fluorescence of SMA imide 1:1 elution sample (T1 to T11) following 
IMAC purification. Samples were loaded into a 96 well plate and GFP fluorescence was 
measured at excitation of 495nm and an emission of 509nm. GFP Tag Fluorescence in 
Solubilised Sigma-1 Complexes using SMI Imide 1000I Post IMAC Run. 
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GFP fluorescence, could also indicate there is a high level of free GFP in the sample 
due to potentially being cleaved by proteases during protein extraction. For this 
reason, this testing method alone is not suitable for determining the presence of 
bound GFP to sigma-1 and required further testing methods such as in-gel 
fluorescence to determine the molecular weight of the fluorescent complexes 
 
3.5 C43 Cell Line In-gel Fluorescence Results 


























Once we had gained peak elutions from the AKTA start purification system and 
measured the GFP fluorescence via a plate reader it was necessary to determine 
the molecular weight of the protein emitting this fluorescence. This was done by 
using the pre-prepared in-gel fluorescence sample buffer and following the 
previously specified protocol. As we can see in figure 24, In lane 1 the Precision 
Plus ProteinTM Dual Colour ladder emits fluorescence at bands of 75KDa and 
25KDa enabling easy tracking of samples in the gel. Using a CCD camera, we could 
Figure 25: 10-250 kDa 
Precision Plus ProteinTM 
Dual Colour (pre-stained) 
ladder2. Precision Plus 
Protein Ladder Reference 
Figure 24: In gel-fluorescence using IGFSB as a marker for sigma-
1 GFP tagged complexes. Lane 1 contains the Precision Plus 
ProteinTM Dual Colour (pre-stained) ladder, lane 2 contains 
concentrated elution 8 and lane 3 contains concentrated elution 9 
post 0.1% LMNG & 0.01 CHS AKTA Start purification. In Gel-
Fluorescence of LMNG and CHS Sigma-1 GFP tagged Solubilised 
Complexes. 
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visualise the elutions fluorescence at 460nm and 515nm cut-off using blue light. 
In lane 2 for elution 8 we see a strong fluorescence for at 25KDa and 75KDa, which 
can also be confirmed lane 3 elution 9.  
 
Prior to this procedure we expected fluorescence visibility at around 50 to 60KDa 
for this to be sigma-1 GFP tagged complexes. The presence of GFP fluorescence at 
around 25KDa was an indication that there were free GFP complexes in the sample 
unbound to our desired protein. Whereas fluorescence at 75KDa indicated that 
expression of our desired protein complexes could be abnormal or misfolded in 
some way. Furthermore, a simpler explanation could be the possibility of 




























Figure 26: In gel-fluorescence using IG-FSB as a marker for sigma-1 GFP 
tagged complexes. Lane 1 contains the Precision Plus ProteinTM Dual Colour 
(pre-stained) ladder, lane 2 contains concentrated elution 8 (2% SMA 
Imide) and lane 3 contains concentrated CLIC1-GFP reference sample. In 
Gel-Fluorescence of SMA 2000I Sigma-1 GFP tagged Solubilised Complexes Vs. 
CLIC-GFP Reference  
Figure 27: 10-250 kDa 
Precision Plus 
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Similarly, to the previously explained in-gel fluorescence result we see the same 
trend when analysing the concentrated sigma-1 elution solubilised by 2% SMA 
imide 1:1 nanodiscs. Due to the unexpected results seen in the 0.1% LMNG 
solubilised sample we decided to compare our sigma-1 GFP tagged sample to a 
protein that’s expression, purification and characterisation protocols had been 
effectively optimised. The protein we used for this reference was the chloride 
intracellular receptor 1 (CLIC1), as this protein had been previously analysed in 
multiple publications in great detail. CLIC1 has a very similar molecular weight to 
sigma-1 at 27KDa and when tagged with GFP it should also have a molecular 
weight of around 50 to 60KDa. As we can see in Figure 26, lane 2 containing the 
sigma-1 GFP tagged SMA imide solubilised elution there is no distinct fluorescent 
bands at 50KDa. When we compared this our CLIC1 reference sample we can see 
a clear difference to that of our elution sample.  
 
Furthermore, it is clear to see that the CLIC1 reference sample emits strong GFP 
fluorescence at around 50KDa whereas our sigma-1 solubilised via SMA imide 
nanodiscs does not. The only indication that we see in our elution sample is 
minimal GFP fluorescence at both 25KDa and 75KDa as seen in the 0.1% LMNG 
sigma-1 gel. This second gel may support the ladder contamination theory 
previously explained, as both gels appear identical results for the AKTA start 
purification elution sample. Overall, the data obtained for the in-gel fluorescence 
of our eluted samples via all solubilisation techniques were unexpected and 
definitive conclusions were had to come by. Although the results for in-gel 
fluorescence appeared to be unpromising it was still necessary to continue 
forward with our purification procedures for sigma-1. Once analysis of in-gel 
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Gel filtration chromatography can be divided into two major phases; Stationary 
Phase and the Mobile Phase. The stationary phase is referred to the point at which 
the size-exclusion column is void of sample flow or running buffer whereas the 
mobile phase can be defined as the supply of sample flow or running buffer 
through the column. Smaller molecules tend to have a greater access to stationary 
phase enabling them to pass through the sepharos beads at a much slower pace. 
Larger molecules tend to have an inaccessibility to stationary phase causing them 
to elute at a much earlier accumulated volume and time during a run. This 
inaccessibility to stationary phase is referred to as the void volume (V0) and this 
is a useful tool that can be used in estimating desired protein peak elutions post 
SEC. As smaller molecules and low molecular weight proteins readily gain access 
to stationary phase, they tend to elute before one column volume has passed 





















































Size Exclusion Chromatography data for sigma-1 solubilised with 2% SMA 
Imide (1:1) Nanodiscs
Potential sigma-1 GFP tagged SMA 
imide nanodiscs
Figure 28: Shows size exclusion chromatography data for sigma-1 solubilised with 2% SMA 
imide (1:1) Nanodiscs. Here we see detection for UV absorbance at 280nm and GFP 
fluorescence at excitation 495 nm and emission of 509nm. Size Exclusion Chromatography 
of 2% SMA Imide 1000I Solubilised Sigma-1 GFP Complexes. 
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This latent elution of low molecular weight biomolecules is referred to as the total 
accessible volume (VT), which can be used for column calibration for determining 
the molecular weights of each peak elution. Unfortunately, for our SEC 
purification procedure we were unable to successfully or accurately calibrate our 
column due to a slight compression in the sepharos beads. Furthermore, although 
we were unable to determine an estimated molecular weight of each peak 
elution, it was possible to analyse GFP fluorescence of each elution in order to 
determine which samples were most likely to obtain our desired protein. For this 
SEC procedures the 500μl 2% SMA Imide concentrated sample obtained post 
IMAC purification was injected and run at 0.5mL/min. In figure 28 it is clear to see 
two distinct peaks, one at 13.15mL and the other at 15.5mL of sample running.  
 
 However, as we set up GFP fluorescence for this SEC procedure it was deemed 
necessary to screen UV absorbance peaks simultaneously in order to screen 
selected fractions via SDS-PAGE. The first UV 280nm peak elution at 13.15mL also 
corresponds to an increase in GFP fluorescence readings, however it is not until 
the second peak elution is reached, we see a clear GFP fluorescence 
corresponding to a specific eluting protein. The total estimated fluorescence peak 
reached for elution one was determined at 269.19 RFU, whereas elution two was 
nearly double at 555.4 RFU. Although the fluorescence determined for elution 
peak two was greater than that of elution peak one, this does not necessarily 
indicate that a greater fluorescence emitting elution will contain bound GFP to 
sigma-1. Because of this, it was necessary to screen all elutions for both peak one 
and peak two to be sure that our desired protein was not situated in an 





3.7 SDS-PAGE Screening Post TEV Protease Cleavage 
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As described previously, our TEV cleavage procedure was not performed in 
optimum conditions due to issues with the stability and purification of sigma-1. 
Under optimum conditions such as pH 8.0 and at room temperature, TEV protease 
exhibits a high level of enzymatic activity with a high level of cleavage for the 
ENLYFQG amino acid sequence. As our TEV cleavage procedure was performed in 
pH 7.5 and at 4°C it is unlikely that the activity of our enzyme was at full capability, 
which is evident when analysing our SDS-PAGE gels for this procedure. In figure 
29 we can see this to be true, for this procedure we expected to see no protein 
bands at around 50KDa following TEV cleavage of GFP from sigma-1. However, in 
figure 29 we see bands in the elution sample at 50KDa and around 40KDa which 
indicated the TEV cleavage procedure was not fully effective. In addition, we see 




Isolated Sigma-1 Solubilised 
by 2% SMA Imide  
Figure 29: Tev cleavage procedure performed in pH 7.5 lysis buffer and at 
4°C. Lane one contains the PageRulerTM protein ladder, lane two contains 
our elution sample, lane three contains a wash sample and lane 4 contains 
our flow through sample. SDS-PAGE Post TEV Cleavage Procedure of 
Solubilised Sigma-1 GFP Complexes in 2% SMA Imide 1000I 
 
Figure 30: 5-250 
kDa PageRulerTM 
protein ladder 23. 
Page Ruler Protein 
Ladder Reference 
       LAD      Elution      Wash        Flow 
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protease or free GFP molecular weight. Furthermore, when analysing the wash 
sample on the gel we also see a faint protein band at 50KDa which supports the 
idea the TEV protease activity was hindered by the protocol. A promising result is 
when we begin to analyse the flow through sample on the gel, and we see two 
individual protein bands at between 20KDa to 30KDa. As our desired proteins HIS-
tag was cleaved during the TEV procedure we would expect to see observe this 
protein, isolated in a flow through sample non previously bound to the nickel 
column. It is highly likely that the two bands seen in the flow through sample is 
isolated sigma-1 and TEV protease that has become unbound to the nickel 
column.   
 
3.8 TEM For Identification of Nanodisc Complexes 
Once there was a strong indication for the solubilisation of the sigma-1 receptor 
using 2% SMA imide (1:1), we tested our size exclusion chromatography peak 
elution samples to identify the formation of nanodisc complexes. In figure 31, we 
can see a profound number of nanodisc like formations at a resolution of 100nm. 
Upon analysing these nanodiscs formations, we estimated an average diameter of 
19nm per disc. When comparing these images to previous publications such as 
seen in Swainsbury et al TEM images on 2:1 SMA nanodisc complexes. It is clear 
to see distinct similarities between our results and their findings. In their 
publication, they identified the size of their SMA nanodisc formations to be an 
estimated 13nm in diameter with the presence of aggregated artefacts (100nm in 
size) likely to be mass clumps of nanodiscs. As we can see in our sample a profound 
concentration of nanodiscs throughout, it is likely that this had an impact on the 
efficiency of our primary AKTA purification for the 2% SMA Imide (1:1) sigma-1 
samples. In recent publications, it has been implicated that free nanodisc 
formations may result in the interference of polyhistidine tags with nickel columns 
during the sample running phase. This could be a potential factor for why we do 
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Figure 31: TEM image at 100nm for the identification of 2% SMA imide (1:1) nanodiscs in 
our SEC purified Sigma-1 GFP Samples. Transmission Electron Microscopy Of 2% SMA 
Imide (1:1) Nanodiscs at 100nm. 
Figure 32: TEM image at 20nm for the identification of 2% SMA imide (1:1) nanodiscs 
in our SEC purified Sigma-1 GFP Samples. Transmission Electron Microscopy of 2% 
SMA Imide (1:1) Nanodiscs at 20nm. 
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3.9 C43 expression results in relation to past literature 
The results obtained for the C43 expression protocol of the sigma-1 highlights the 
challenges of successfully isolating membrane proteins. Currently, there have 
been very few publications that have demonstrated successful expression of the 
sigma-1 receptor in C43 being functionally active. A study published in 2013 by 
Gromek et al, used BL21 and C43 cell lines for the expression of sigma-1 receptor 
extracted gene from the guinea pig. During their cloning they fused sigma-1 
receptor to the maltose binding protein (MBP) as this protein tag has shown to 
increase recombinant protein yield and solubilisation stability. Similarly, this study 
concluded sufficient extraction and solubilisation using detergent based methods 
such as DDM and Triton X-100.  
Although, they identified a lower level of sigma-1 functional activity when using 
these detergents individually rather than used in combination with each other. 
Overall the the yields obtained of active sigma-1 were not desirable, even after 
comparing expression levels to other E. coli cell lines such as C41 strains. 
Unfortunately, this study did not provide data for their size-exclusion 
chromatography and AKTA start purification runs. However, they did conclude 
these purification methods to be sufficient in isolating the sigma-1 receptor and 
identified that the addition of supplemented detergent to purification systems 
increased the functional yield of the protein after assessing via ligand binding 
studies. In comparison, a previous study published in 2006 by Ramachandran et 
al, also identified similar results when expressing the sigma-1 receptor in E. coli 
expression systems. This study identified that when the sigma-1 receptor is 
expressed alone without any additional tags such as GFP and MBP, the formation 
of cell inclusion bodies is evident26. 
 In contrast even when a GFP tag was present in our study, we also identified the 
formation of inclusion bodies when induction took place at higher incubation 
temperatures (>15°C). However, this could also be due to the development of 
cellular toxicity due to overexpression of both the sigma-1 receptor and GFP at 
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once. Once the researchers of this study successfully expressed the sigma-1 
receptor with its counterpart MBP tag, they also identified a greater level of 
functional stability in the protein when using a combination of detergent based 
methods i.e. CHAPS & triton X-100, just as in Gromek et al findings25. Just as seen 
our TEV protease cleavage procedure Ramachandran et al identified the isolated 
sigma-1 receptor at a molecular weight of 25KDa run on a 12% SDS-PAGE gel.  
 
They concluded this isolated sigma-1 protein to also be functionally active using 
[3H]-(+)-pentazocine for ligand binding assays. Unfortunately, the researchers of 
this study did not include data obtained for their purification methods (SEC & 
IMAC) in their publication, therefore we unable to compare our data to their 
findings. However, the Shmidt et al study concluded that the sigma-1 receptor 
appeared to run as high molecular weight oligomers of high biochemical purity 













Figure 33: Analytical size exclusion of purified σ1 receptor in LMNG/CHS detergent 
buffer on a Superdex 200 column. Image taken from Shmidt et al 2016 publication 
‘the crystal structure of the human sigma-1 receptor’.11 Schmidt et al LMNG and 
CHS Size Exclusion Chromatography Data on Isolated Sigma-1 from Sf9 Cells 
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As we can see in figure 33, there is a clear distinct high-resolution peak ranging 
between 10 to 15mL obtained from the Shmidt et al SEC purification of the sigma-
1 receptor. During this study, they also used a Superdex 200 10/300 GL (25mL) 
size-exclusion column for their secondary purification and it is clear to see a 
correlation between their results and ours. Although we do not have data for or 
sigma-1 0.01% LMNG and 0.001% CHS SEC run, we can see a clear similarity when 
comparing this to the graph of the sigma-1 2% SMA imide (1:1) SEC purification 
run. In our study we also identified peak elutions ranging between 10 to 15mL for 
all of our solubilisation technique SEC runs. Furthermore, although there is not a 
sufficient amount of available literature to which we can compare our findings 
directly to, there is still many strong indications that suggest successful expression 
and isolation of our target protein in the C43 expression system. 
Saccharomyces Cerevisiae Expression System Results 
and Discussion 































OD600 Data Of 500mL INSVc1 Growth Cultures During Gal1 repression 
& 2% Galactose Induction For Sigma-1 Expression 
Figure 34: Shows OD600 data pre and post induction of the INVSc1 cell line. Date points in grey 
are readings taken before induction and data points in black are readings taken post 2% 
galactose induction. OD600 Growth Data of INSVc1 cell line prior and post 2% Galactose 
Induction. 
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As we can see, figure 34 demonstrates a clear difference between the growth 
cycles of C43 compared to INVSc1. In order to achieve an OD of 0.67 from this 
data, it required 8 hours of incubation at 30°C. When comparing this to the 
optimum OD600 of our C43 vector, it is clear to that this expression system required 
a fraction of that time (140 minutes) to be suitable for induction. However, as we 
can see the doubling time of this cell line appears to show normal yeast growth as 
they cells appear to be doubling every 2 hours. Upon induction with a 2% sterile 
stock of Galactose in -URA medium, we see that the OD600 of the growth culture 
has doubled when hour 16 has been reached. Again, this is to be expected for 
normal cellular growth and based on the fact galactose increases culture density 
often resulting in higher OD600 results.  
 
After 24 hours has passed, the maximum incubation timepoint has been reached 
which indicated sufficient protein expression of sigma-1 had been achieved. At 
hour 24 a final OD600 of 1.68 was recorded, which is a normal OD600 for a yeast 
growth culture that has been induced and incubated for a significant time span. 
We can see from both figures that there is a steady rate of growth up until hour 
8, then we see a sharp increase from hour 16 followed by an indication of a 
stationary phase in the INSVc1 growth. This is to be expected as the culture 
reached its maximum timepoint, which signals that the nutrients in the medium 
had become significantly depleted. As INSVc1 cells are much larger than that of 
bacteria, we are unable to accurately calculate the cellular densities of all OD600 
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3.11 In-gel Fluorescence Results Post INSVc1 2% Galactose Induction 


























In we figure, we can see a comparison in GFP fluorescence between control 
INSVc1 transformed cells to 2% galactose induced INSVc1 transformed cells.  In 
this gel it is not possible to identify any indications for the presence of sigma-1 
GFP tagged complexes in both the control and induced cell. However, as seen 
before in the in-gel fluorescence for the sigma-1 C43 expressed samples, we see 
fluorescence at 75KDa and 25KDa. At this stage it is more than likely that these 
signals are nothing more than false positives due to the high fluorescence of the 
protein ladder in the adjacent lane 1. It is clear to see this method of GFP 
fluorescence requires optimisation due to these unexpected results in both the 





Figure 36: 10-250 kDa Precision 
Plus ProteinTM Dual Colour (pre-
stained) ladder24. Precision Plus 
Protein Ladder Reference 
Figure 35: In gel-fluorescence using IGFSB as a marker for 
sigma-1 GFP tagged complexes. Lane 1 contains the 
Precision Plus ProteinTM Dual Colour (pre-stained) ladder, 
lane 2 control INSVc1 transformed cells lane 3 contains 2% 
galactose induced INSVc1 transformed cells. In Gel 
Fluorescence of Sigma-1 GFP Tagged Complexes Expressed 
in INSVc1 Post 2% Galactose Induction. 
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By analysing this gel for the elutions obtained post IMAC purification it is clear to 
see presence of a profound number of proteins within the samples. Theoretically, 
if the purification was at the highest level of efficiency, we would expect to see 
fewer proteins within each elution as we expect the only protein to have affinity 
for the nickel is the sigma-1 receptor based on the presence of a N-terminus GFP 
His-tag. Although, we do see a significant level of proteins throughout the 
elutions, flow through, and wash samples we see the highest band intensities in 
elutions T7 and T8. Specifically, these intensities are at varying molecular weights 
from 50KDa to 70KDa. This was a strong indication that the INVSc1 were over 
expressing our desired protein as we had seen similar results in SDS-PAGE gels for 
    LAD T1-4 T5   T6 T7 T8   T9   T10 T11 T12 T13 T14 T15 T16 T17 FT WH 
Figure 37: Shows SDS-PAGE gel run for the elutions (T) post IMAC 
purification using 0.1% LMNG and 0.01% CHS for solubilisation. Lane 1 
contains the PageRulerTM protein ladder, lane 2 contains a 
concentrated sample of elutions T1 to T4, lane 3 to lane 17 contains 
elutions T5 to T17, lane 18 contains flow through sample and lane 19 
contains a wash sample. SDS-PAGE Result Post IMAC Run on LMNG 
and CHS Solubilised Sigma-1 GFP Complexes   
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C43. Furthermore, as these gels showed a strong indication for the presence of 
our target protein it was necessary to investigate further and separate all of these 
proteins into single fractions via size exclusion chromatography. 
 











The 4mL elutions T5 to T10 run on the SDS-PAGE gel post IMAC purification were 
spin concentrated down to 500 microlitres to be injected through a 25mL 
Superdex 2000GL column. Once injected the sample buffer was applied at a flow 
rate of 0.5mL/min to obtain individual fractions of 0.5mL for the purpose of 
protein separation. As we can see from the SEC graph in figure 39, we see two 





























SEC Of Concentrated 0.01% LMNG & 0.001% Sigma-1 Samples 
Expressed In INVc1 Cell Line
Peak 2: 14.2  
mL
Figure 39: Reports the size-exclusion chromatography data that we obtained for the 
concentrated elutions obtained from the primary IMAC purification phase in INVSc1. In 
this graph we see two peaks at 13.3mL and 14.2mL with good resolution peaks. Size 
Exclusion Chromatography Graph of LMNG and CHS Solubilised Sigma-1 GFP 
Complexes Expressed in INSVc1 Cells.
Peak 1: 13.3mL 
Peak 3: 17.5 mL 
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seen in SEC graph for the C43 expression system. In the SMA imide 1:1 sigma-1 
purification the first peak elution was also estimated at 13.3mL which can also be 
in to be the same in this data.  Although this SEC purification was not aided by a 
GFP fluorescence detector, it is safe to say that it is more than likely this fraction 
is our sigma-1 GFP tagged complex. The second peak elution recorded at 507 AU 
could also potentially be our desired protein complex or free GFP which could 
have been cleaved during extraction. In figure 39, we also late peak elutions 
indicating that something of a smaller molecular weight is eluting. Theoretically 
this could be the presence of varying sizes of micelles, as this purification was 
facilitated with a concentration of 0.01% LMNG and 0.001% CHS supplemented to 
the running buffer. Furthermore, by analysing this data it was necessary to collect 
fractions from both elutions to screen via SDS-PAGE for protein molecular weights 




The 0.5mL fractions collected post SEC purification, were run on an SDS-PAGE gel 
to assess both peak elutions for identification of probable molecular weights. As 
we can see in figure 39, peak 1 (13.2mL: F26 to F27) did not contain any significant 
concentration of proteins that could be deemed as the presence of the sigma-1 
receptor. In addition, peak 2 (14.2mL: F28 to F30) did not contain any proteins at 
the expected molecular weight of 50KDa except a low intensity band correlating 
at about 35KDa. However, after including an additional small peak elution (peak 
elution 3: 17.5mL) on the SDS-PAGE gel, we identified the presence of intense 
bands at 50KDa. These bands at 50KDa were identified at in fractions 33 to 35, 
with also the presence of bands at 30KDa to 40KDa. 
3.14 Gel Filtration Peak Elution SDS-PAGE Screening 
Bradley Hilton 































The identification of bands at proteins at 50KDa was a positive indication for the 
presence of the sigma-1 receptor in the INVSc1 cell line. Similarly, to that of the 
C43 expression vector we also saw intense protein bands at around 30 to 40KDa. 
This reoccurring trend of lower molecular weight proteins being present as well 
as those at 50KDa within the samples, is a strong indication that our sigma-1 
complexes may be getting cleaved to some structural level. Furthermore, as the 
results obtained for the INVSc1 and C43 systems demonstrated similar results at 
this stage of the purification, we deemed it necessary to continue forward into 
concentrating these fractions for TEV protease cleavage.  
LAD    F26   F27   F28   F29   F30  F31  F32    F33     F34    F35 
Figure 40: SDS-PAGE gel post SEC purification procedure on two 
eluted peak fractions. In lane one we the PageRulerTM protein 
ladder, lane 2 to 3 we see fractions F26 and 27 (peak 1), lane 4 
to 6 we see fractions F28 to F30 (peak 2) and lane 7 to 11 we 
see fractions F31 to F35 (peak 3). SDS-PAGE Result of Elution 
Peaks Post SEC of INSVc1 Expressed Sigma-1 GFP Tagged 
Complexes. 
Figure 41: 5-250kDa 
PageRulerTM protein 
ladder23. PageRuler 
Protein Ladder Reference 
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Once we had successfully concentrated our SEC fraction samples for TEV cleavage 
it was necessary to purify potential isolated sigma-1 via IMAC. By analysing figure 
42, we can see bands two distinct protein bands present within the imidazole 
elution sample. One of these protein bands is at 50KDa and the other has a slightly 
lower molecular weight between 40 to 50KDa. It is likely that the protein band at 
50KDa is still sigma-1 tagged to GFP complexes due to poor TEV protease cleavage 
incubation conditions. The 40 to 50KDa protein band in the imidazole elution 
sample is likely to be a cleaved construct of the sigma-1 GFP tagged complex, 
however from this data we are unable to determine the exact structural cleavage 
location on the protein. In contrast, when analysing this gel, we identified no 









Figure 42: SDS-PAGE gel post IMAC purification procedure on the sigma-1 
receptor cleaved from GFP via TEV protease cleavage. Lane 1 we see the 
PageRulerTM ladder, lane 2 the elution sample, lane 3 the wash sample and 
lane 4 the flow through sample. SDS-PAGE Result post IMAC run on TEV 
cleaved Sigma-1 Expressed in INSVc1. 
 
LAD         ET     WH    FT 
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promising result is when we analyse the flow through sample for the presence for 
isolated sigma-1. 
 
After analysing the flow through sample, we identified two distinct bands in close 
proximity to one another. Here, we estimate the lower molecular weight protein 
at 25KDa and the higher molecular weight protein at around 27KDa. The protein 
band identified at 25KDa is more than likely to be isolated sigma-1 as our 
expressed DNA fragment sequence equates to this molecular weight i.e. 669 bp 
equates to 25.1 KDa. Whereas, the protein identified at 27KDa within the flow 
through sample is likely to be TEV protease that has not successfully remained 
bound to the nickel column during the loading phase of IMAC. Theoretically, we 
would expect to see the TEV protease within the elution sample due its possession 
of a His-tag in its expressed structure however, the presence of this may indicate 
adverse characteristics of our purification procedure. Due to the presence of TEV 
protease within the flow through sample, it is difficult to make a definitive 
conclusion that the protein seen at 25KDa is in fact the sigma-1 receptor. In 
addition, this draws the possibility of this band potentially being free GFP as this 
protein also has a similar molecular weight to both TEV protease and sigma-1. 
 
3. 16 S. Cerevisiae Sigma-1 Expression in Relation to Past Literature 
 
Currently there have been little research publications regarding the expression of 
the sigma-1 receptor in yeast cell lines, of which is unexpected as the sigma-1 
receptor is shares close homology to the yeast C8-C7 sterol isomerase expressed 
by the ERG2 gene. Interestingly, this yeast protein also shares a similar 
pharmacological profile to the sigma-1 receptor and is also able to bind to its 
ligands with high affinity. Furthermore, we are unable to compare our results to 
past literature regarding the expression of the sigma-1 receptor in yeast, however 
it is possible to compare our findings to the Newstead et al publication27. 
Although, this publication aimed at providing an optimised membrane protein 
expression protocol, it does allow the researcher to identify key characteristics of 
successful growth in yeast. In the Newstead et al membrane protein expression 
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publication they identified a sufficient induction, OD600 at 0.6 for maximum 
protein expression. When comparing our INSVc1 growth data pre and post 
induction we can confirmed a normal growth curve and doubling time of our 
INSVc1 cells. However, when comparing our in gel-fluorescence data are unable 
to successfully identify sigma-1 tagged GFP complexes at 50KDa. At this stage, it 
was a strong indication that there may have been cloning issues with our LEU2 
construct. It is possible that the sigma-1 fragment was not successfully 
incorporated to the LEU2 vector containing the gene for GFP. Unfortunately, the 
final cloned LEU2 sigma-1 construct was not sent for amino acid sequencing which 
may have resulted in false positive results. In addition, it may have been beneficial 
to run DNA electrophoresis gels on all of our amplified PCR fragments before and 
after transformation to confirm correct DNA fragment LEU2 construct insertion. 
 
Although we finally identified an isolated protein with a molecular weight of 
25KDa via SDS-PAGE, it did not test positive for the sigma-1 receptor through 
western blot screening in any of the INVSc1 samples.  In the Newstead et al 
protocol, the researchers also estimated the total membrane overexpression 
levels using a microplate spectrofluorometer post culture induction with 2% 
galactose. If we had done this during this study, this may have provided us with 
an indication of whether our target protein had been successfully expressed or 
not. Another potential factor that may have resulted into undesirable sigma-1 
expression in our INSVc1 cell line, may be due to the measuring of OD600 post 
induction of our growth culture. This was not followed to the same protocol as 
seen in the Newstead et al study, as they advised removing the culture from 
incubation post induction procedure. This could have potentially resulted in the 
inhibition of sigma-1 expression and lowered cell culture density overall during 
this incubation period. Overall, although we did not successfully isolate the sigma-
1 receptor in INSVc1 cells, it is clear that this expression system requires major 
optimisation. In principle, the use of yeast cell lines for the expression of 
recombinant proteins has been demonstrated to be highly desirable for 
membrane stability and biochemical functionality.  
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Final Results and NMR Studies  


























As we can see in figure 43, the confirmed isolation of the sigma-1 receptor was 
performed in the C43 expression system. After endless attempts to successfully 
isolate the protein using nanodiscs and LMNG detergent, it would be finally 
isolated using the same methods as seen by the Shmidt et al study. In figure 43, 
we see no antibody detection of our desired receptor present within the wash 
sample, which was to be expected due to a previously run SDS-PAGE result. Within 
the flow through sample we see an intense reaction at 25KDa mediated via the 
addition of ECL onto a secondary conjugated HRP antibody. This identification 
concludes the presence of the isolated sigma-1 receptor expressed in C43 cells 
and solubilised by detergent based methods. Interestingly, when we analyse the 
elution sample, we also see the presence of secondary antibody reactions at 
50KDa and 25KDa. The two bands positive for our desired protein at 50KDa are 
LAD  ET FT WH 
Figure 44: 5-250kDa 
Precision Plus ProteinTM 
Dual Colour (pre-
stained) ladder24. 
Precision Plus Protein 
Ladder Reference 
Figure 43: Western blot post TEV cleavage procedure in C43 
expressed sigma 1. The sigma-1 receptor was finally solubilised 
in 0.01% LMNG and 0.001% CHS. Lane 1 is the ladder, lane 2 is 
the elution, lane 3 is the flow through and lane 4 is the wash 
sample. Western Blot Confirmation for Isolated Sigma-1 
Expressed in C43 Cells. 
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likely to be uncleaved sigma-1 GFP tagged complexes due to issues with the TEV 
cleavage procedure. In addition, the second protein detection band just below 
50KDa suggests protein cleavage during our expression protocol. In addition, 
when we analyse the elution sample at 25KDa we also can identify two distinct 
positive results. The first band located at exactly 25KDa corresponds a similar 
result to the flow through sample, indicating this is also isolated sigma-1. 
However, the protein band just above 25KDa (estimated at 30KDa) is likely to be 
a combination of unexpected cleaved sigma-1 and GFP complexes. In order to 
obtain this result via western blot, this project failed multiple times to successfully 
isolate this receptor. When the nanodiscs solubilised sigma-1 samples were tested 
via western blot there was no indication of its presence. This could be due to a 
profound number of protocols, purification, and western blot factors resulting in 
a false negative result. In addition, when the sigma-1 solubilised 0.01% LMNG 
samples expressed in INSVc1 were tested via western blot they also showed no 
indication for the presence of sigma-1. However, this is more than likely due 
cloning issues that lead to false indications throughout the screening procedures 
 
3.18 NMR Studies for the Identification of the Sigma-1 Receptor  
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Testing Sample 1: S1R in 0.1% LMNG (Control Without Drug) 
Testing Sampl  2: S1R (0.2% LMNG) & 15mM Fluoxetine Hydrochloride 
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Figure 45: NMR CMPG (15.5mM fluoxetine hydrochloride) spectra overlay, of all varying 
sample conditions for the experiment. Overview of Complete NMR CMPG Spectra 
Overlay. 
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In figure 45, we identified the CPMG spectra of varying peak intensities for 
15.5mM fluoxetine hydrochloride spectra. This is the spectra overlay consisting of 
individual signals detected for the manipulated sample conditions in the presence 
or absence of the sigma-1 receptor, and varying LMNG concentrations. As we can 
see the 15.5mM fluoxetine hydrochloride sample (without detergent and target 
protein blue peak) correlates almost perfectly to that of the 15.5mM fluoxetine 
hydrochloride/50µM sigma-1 sample supplemented with 0.1% LMNG (magenta 
peak). This allows us to use the 50µM sigma-1 and 0.1% LMNG supplemented 
sample as a control and the 15.5mM fluoxetine without sigma-1 and LMNG as a 
reference for this spectrum. As the concentration of LMNG increased to 0.2%, the 
50µM sigma-1/15.5mM fluoxetine hydrochloride sample (red line), and the 
15.5mM fluoxetine hydrochloride sample without 50µM sigma-1 (green line) 
resulted in a total net loss of peak intensity in both samples.  
Figure 46: Magnified image of Peak Intensities: NMR CMPG (15.5mM fluoxetine 
hydrochloride) spectra overlay, of all varying sample conditions for the experiment. 
Magnified Peak Intensities for the NMR CMPG Spectra Overlay. 
Testing Sample 1: S1R in 0.1% LMNG (Control Without Drug) 
Testing Sample 2: S1R (0.2% LMNG) & 15mM Fluoxetine Hydrochloride 
Sample 3: Fluoxetine Hydrochloride (0.2% LMNG & No Sigma-1) 
Sample 4: 15mM Fluoxetine Hydrochloride (No LMNG & Sigma-) 
Negative Fluoxetine Peak Intensity:  
§ 50µM Sigma-1 (0.2% LMNG) 
Fluoxetine Hydrochloride 
§ 15.5 mM Fluoxetine 
Hydrochloride (0.2% LMNG & 
No Sigma-1) 
Positive Fluoxetine Peak Intensity:  
§ 50µM Sigma-1 /0.1% LMNG (Control) 
§ 15.5mM Fluoxetine Hydrochloride (No 
LMNG & Sigma-1) 
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This is a strong indication that the sigma-1 receptor was binding to the agonist 
compound fluoxetine hydrochloride. This can be concluded as we saw no loss of 
peak intensity in both the 50µM sigma-1 in 0.2% LMNG control sample (without 
drug) and the 15.5mM fluoxetine hydrochloride in 0.2% LMNG sample (without 
sigma-1). This was an extremely positive result, however there was an important 
consideration when making final conclusions on this data. As we also saw a total 
net loss of intensity for the 15.5mM fluoxetine hydrochloride in 0.2% LMNG 
sample without the presence of the sigma-1 receptor, this provides an indication 
that the drug may be interacting with detergent micelle formation. In recent 
years, many publications have demonstrated that certain drugs can bind to 
micelles in various types of detergents. One possible explanation for this may be 
due to interactions of fluoxetine hydrochloride structural aromatics with LMNG’s 
maltose groups. These interactions are considered as undesirable for 
pharmacological studies of specific proteins and for structural characterisation. 
Which demonstrates the adverse responses when solubilising membrane proteins 
with detergent based methods. Furthermore, this hypothesis requires more 














Figure 47: ID proton NMR (15.5mM fluoxetine hydrochloride) spectra overlay, of 
all varying sample conditions for the experiment.  Overview of ID Proton NMR 
Spectra Overlay. 















20190628_Fluoxetine_LMNG01  1  1  /opt/DATA/ukc/2019/jor
   20190628_Fluoxetine_LMNG01  1  1  /opt/DATA/ukc/2019/jor
   20190628_Fluoxetine_LMNG02  1  1  /opt/DATA/ukc/2019/jor
   20190628_Fluoxetine__S1R_LMNG01  1  1  /opt/DATA/ukc/2019/jor
   20190628_Fluoxetine_noLMNG  1  1  /opt/DATA/ukc/2019/jor
Testing Sample 1: 50µM S1R in 0.1% LMNG (Control Without Drug) 
Testing Sample 2: 50µM S1R (0.2% LMNG) & 15mM Fluoxetine Hydrochloride 
Sample 3: 15mM Fluoxetine Hydrochloride (0.2% LMNG & No Sigma-1) Control 
Sample 4: 15mM Fluoxetine Hydrochloride (No LMNG & Sigma-1)  
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After we had successfully obtained data for the CMPG sequence experiment, it 
was decided to run these samples on a standard 1D proton NMR spectrum to 
provide credibility to our hypothesis. In figure 47, we identify a signal overlay 
corresponding to peaks for the identification of our LMNG detergent in the sample 
buffer. The data from this spectrum strongly supports the previous hypothesis 
regarding our agonist’s interactions with the sample buffer detergent. When we 
analyse the 15.5mM fluoxetine hydrochloride (magenta line: without LMNG and 
sigma-1) we see a complete disappearance of the peak, which is to be expected 
for this reference sample. However, when we analyse the other samples, we see 
distinct peaks at varying intensity for the concentration of LMNG in the samples. 
Firstly, when we see compare the LMNG concentration for the 50µM sigma-1, in 
0.2% LMNG 15mM fluoxetine hydrochloride (green peak) against the 15mM 
fluoxetine hydrochloride (red peak: control sample) in 0.2% LMNG with no sigma-
1, it is clear to see a difference in LMNG concentration. The 50µM sigma-1, in 0.2% 
LMNG 15mM fluoxetine hydrochloride appears to have a greater LMNG 





Testing Sample 1: 50µM S1R in 0.1% LMNG (Control Without Drug) 
Testing Sample 2: 50µM S1R (0.2% LMNG) & 15mM Fluoxetine Hydrochloride 
Sample 3: 15mM Fluoxetine Hydrochloride (0.2% LMNG & No Sigma-1) Control 
Sample 4: 15mM Fluoxetine Hydrochloride (No LMNG & Sigma-1)  
Positive Fluoxetine Peak Intensity:  
§ 50µM Sigma-1 In 0.1% LMNG (Control)  
§ 15.5mM Fluoxetine Hydrochloride 
(0.2% LMNG & No Sigma-1)  
§ 50µM Sigma-1 (0.2% LMNG) and 
15.5mM Fluoxetine Hydrochloride 
Negative Fluoxetine Peak Intensity:  
§ 15.5mM Fluoxetine 




Figure 48: Magnified image of Peak Intensities: 1D proton NMR (15.5mM fluoxetine 
hydrochloride) spectra overlay, of all varying sample conditions for the experiment. 
Magnified Peak intensities of 1D Proton NMR Spectra Overlay 
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This makes it difficult to determine whether the sigma-1 receptor is directly 
binding to the agonist or if the LMNG detergent is binding to the drug. Although 
we could not conclude whether the drug was binding to micelles or the sigma-1 
receptor, the data retrieved from the experiments highlights the difficulties in 
detergent based methods. Unfortunately, as we were unable to successfully 
solubilise the sigma-1 receptor in nanodiscs we are unable to compare this to the 
data obtained for our detergent based protocol. Furthermore, these NMR 
experiments demonstrate the potential for further NMR research into using C43 
cell lines as an expression system for the sigma-1 receptor. In addition, it would 
be advisable in future structural research to determine whether different 
expression systems result in biochemical changes to that of expressed protein. As 
current expression systems in eukaryotic and prokaryotic organisms offer varying 
post translational modifications to the synthesised protein depending on the cell 
line of choice.  
 
3.19 Protocol Optimisation Considerations for The Expression of The Sigma-1 
Receptor 
 
The successful expression and purification of the sigma-1 receptor has proved to 
be a challenging objective given the results obtained during his project. Although 
we were able to express the sigma-1 receptor using the C43 cell line, we were still 
unable to effectively solubilise the receptor using nanodisc technology and in 
INSVc1. This was more than likely due protocol issues regarding expression and 
solubilisation of this receptor due to some of the unexpected results obtained. 
One of the most important optimisation considerations for this project should be 
an increased analysis when preforming cloning for a designed construct. As we did 
not implement DNA electrophoresis, nor send our LEU2 final construct for 
sequencing it is likely that the sigma-1 fragment was not correctly inserted to this 
vector. This should be a crucial optimisation if further research is to be conducted, 
as this will avoid potential false positive results and reduce time spent in the 
expression of the receptor in this system. 
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Furthermore, it is also vital that the solubilisation of the sigma-1 receptor is 
optimised to identify the best suited nanodisc technology for its extraction. In this 
project we predominantly used SMA 2:1 and SMA imide 1:1 nanodisc solubilised 
copolymers for this extraction. It may be necessary to try the formulations of 
copolymer resins such as the SMA imide 2:1 or the SMA 3:1, to identify whether 
these produce better results. In addition, it may be advisable to assess these 
nanodiscs further using methods such as dynamic light scattering (DLS) and Zita-
potential to assess the structural size, molecular weight and stability of these disc 
formations, once the sigma-1 receptor has been extracted. This would enable us 
to assess whether these nanodiscs are degrading, as this would result in the 
insolubility of the receptor and therefore result in protein precipitation in 
solution. Currently, there is little research that has optimised the use of these 
nanodiscs for membrane protein extraction. Therefore, factors such as pH and 




The sigma non-opioid intracellular receptor 1 is a highly important yet poorly 
understood membrane chaperone protein. Previous publications have also 
concluded the challenges they have encountered when trying to express and 
solubilise this protein in almost all expression systems. Studies such as that of the 
2016 Shmidt et al study, have highlighted the usefulness of using expression 
systems such as Sf9 insect cells in producing high yield and stable sigma-1. Our 
findings also clearly correlate with the challenges of previous publications into the 
expression of this protein. After a profound number of attempts to solubilise the 
receptor in C43 using SMA 2:1 and SMA imide 1:1 nanodiscs, we failed in doing 
so. This can also be said for the expression and all solubilisation techniques used 
in the INVSc1 cell line.  
 
However, a positive outcome of this project was that we were able to successfully 
extract and solubilise the receptor in C43 using varying concentrations of LMNG 
and CHS. In a last attempt before attempting expression in Sf9 insect cells, we 
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confirmed the isolation of the receptor via western blot. This was a significant 
achievement as very few publications have been able to successfully express this 
receptor in prokaryotic cell lines. The successful expression of the sigma-1 
receptor in C43 with detergent based techniques may reduce the time and 
resources for its research. It is well publicised that both mammalian and insect cell 
lines require a significant level of time to transfect and expressed desired proteins. 
Therefore, it may be necessary for future research to optimise the C43 expression 
system for the sigma-1 receptor and analyse its biochemical functionality when 
solubilised. Overall, the data obtained in this research project whether that be 
positive or negative results, allows future researchers of this protein to optimise 
its expression to higher standards. In addition, for future research it be interesting 
to determine whether the sigma-1 receptor can be successfully expressed in yeast 
cell lines and if upcoming nanodisc technology offers a better level of solubility 
then current detergent-based methods. 
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